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Interstitial fluid (ISF) surrounds the parenchymal cells of the brain and spinal cord while cerebrospinal fluid (CSF) fills
the larger spaces within and around the CNS. Regulation of the composition and volume of these fluids is
important for effective functioning of brain cells and is achieved by barriers that prevent free exchange between
CNS and blood and by mechanisms that secrete fluid of controlled composition into the brain and distribute and
reabsorb it. Structures associated with this regular fluid turnover include the choroid plexuses, brain capillaries
comprising the blood-brain barrier, arachnoid villi and perineural spaces penetrating the cribriform plate. ISF flow,
estimated from rates of removal of markers from the brain, has been thought to reflect rates of fluid secretion
across the blood-brain barrier, although this has been questioned because measurements were made under barbiturate
anaesthesia possibly affecting secretion and flow and because CSF influx to the parenchyma via perivascular routes
may deliver fluid independently of blood-brain barrier secretion. Fluid secretion at the blood-brain barrier is provided
by specific transporters that generate solute fluxes so creating osmotic gradients that force water to follow. Any flow
due to hydrostatic pressures driving water across the barrier soon ceases unless accompanied by solute transport
because water movements modify solute concentrations. CSF is thought to be derived primarily from secretion by the
choroid plexuses. Flow rates measured using phase contrast magnetic resonance imaging reveal CSF movements to be
more rapid and variable than previously supposed, even implying that under some circumstances net flow through the
cerebral aqueduct may be reversed with net flow into the third and lateral ventricles. Such reversed flow requires there
to be alternative sites for both generation and removal of CSF. Fluorescent tracer analysis has shown that fluid flow can
occur from CSF into parenchyma along periarterial spaces. Whether this represents net fluid flow and whether there is
subsequent flow through the interstitium and net flow out of the cortex via perivenous routes, described as glymphatic
circulation, remains to be established. Modern techniques have revealed complex fluid movements within the brain.
This review provides a critical evaluation of the data.
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The fluids that surround the brain and bathe the cells
within it play several important roles. They provide the
most suitable ionic and nutrient microenvironment to
allow neurons and associated cells to function correctly:
they deliver all the substances the cells require and re-
move unwanted material and they provide a cushion
against physical damage. Hence regulation of compos-
ition, volume and turnover of these fluids is vital. To
allow this regulation there are barriers that prevent free
exchange of material between brain and blood, mecha-
nisms that secrete fluid of controlled composition into
the brain, and mechanisms that reabsorb, eventually to
blood, the extracellular fluids whatever their compos-
ition. Structures associated with this regulation include
those generating the fluid, i.e. the choroid plexuses and
the brain capillaries that make up the blood-CSF and
blood-brain barriers, respectively, and those able to re-
move the fluid, e.g. the arachnoid villi and the perineural
spaces of nerves penetrating the cribriform plate. This
review considers the relative contribution of these struc-
tures in secreting and removing the fluids and evaluates
the evidence for the various ideas of how fluid secreted
into the brain may move through the brain parenchyma
and thence exit to the periphery.
The traditional view is that the choroid plexuses se-
crete the major portion of the cerebrospinal fluid (CSF)
surrounding the brain while the blood-brain barrier has
been thought to make a much smaller contribution to
fluid production, generating interstitial fluid (ISF) that
drains into CSF. Comparisons between these interfaces
with regard to their rates of secretion are considered in
sections 3 and 4. Ideas regarding the relative importance
of these structures in regulating brain fluid may need to
be reassessed and will be discussed further in a later
publication. Many of the topics considered in this review
have been discussed on previous occasions. The reader
interested in accounts of earlier work with references
should consult a number of excellent reviews: [1-3] for
anatomy and generally [4-14]. Recently, Damkier et al.
[15] have presented a comprehensive account of the
mechanisms of secretion by the choroid plexuses, Pollay
[16] has discussed the routes for absorption of CSF and
Brinker et al. [17] have surveyed topics of current inter-



































Figure 1 Structures of the brain considered in this review. a) Mid-
sagittal section from nose to the back of the head incorporating images
of the lateral ventricles that lie to each side of the section. CSF filled
spaces are shown in blue, blood filled spaces in pale red. The choroid
plexuses are shown in darker red. b) Enlarged view of surface of a lateral
ventricle at (E). c) Enlarged view of the cortical surface at (F). The glia
limitans is a mat of glial processes. d) Drawing showing the relationships
between the arachnoid membrane, the pia mater, the subarachnoid
space, and the vasculature supplying the cortex. As described by Zhang
et al. for the artery “the sheath has been cut away to show that the
periarterial spaces (PAS) of the intracerebral and extracerebral arteries are
in continuity. The layer of pial cells becomes perforated (PF) and
incomplete as smooth muscle cells are lost from the smaller branches of
the artery. The pial sheath finally disappears as the perivascular spaces
are obliterated around capillaries (CAPS). Perivascular spaces around the
vein (right of picture) are confluent with the subpial space and only small
numbers of pial cells are associated with the vessel wall” [23]. The cortical
boundary along these vessels is formed by glial foot-processes. The
graphic elements in a) and b) and in c) with minor extensions are taken
with permission from Figure one of Strazielle et al. [19] and relabelled.
d) is reproduced with permission from Figure ten in [23] and partially
relabelled. R.O. Weller (personal communication) has emphasized that
the spaces shown between the arterial wall and the pial sheath and
between the sheath and the glial end-feet were virtual spaces in their
electron micrographs. The periarterial spaces are also portrayed in Figure 6.
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attention to factors that can regulate or modulate secre-
tion and has considered the changes that occur in focal
oedema. Strazielle and Ghersi-Egea [19] have discussed
the structure and function of the blood-brain interfaces
and Engelhardt and Sorokin [20] and Luissant et al. [21]
have reviewed the molecular basis and properties of the
tight junctions important for barrier function.
1.2 The anatomy and terminology
The contents of the skull (Figure 1) consist of the follow-
ing: the brain parenchyma comprising cells surrounded by
ISF together with connective tissue; the vasculature; the
meninges overlying the brain; and the CSF that fills the
ventricles within the brain and the spaces on its outer
surfaces. The ISF, blood plasma and CSF collectively
make up the extracellular fluid of the brain and spinal
cord. Working inwards from the skull (Figure 1c), there
is a thick supporting layer of tissue (the dura), another
connective tissue layer (the arachnoid membrane), the
pia mater and the brain parenchyma with its glial outer
surface. The arachnoid membrane and pia mater are
separated by the subarachnoid space that is bridged by
chordae and larger trabeculae (Figure 1d). The space
between the pia mater and the parenchyma, called the
subpial space or space of His, may be a virtual space, i.e.
with zero thickness [1,22]. The parenchyma is made up
of cells, e.g. neurons and glia, the extracellular matrix
and ISF that pervades the matrix and fills the spaces be-
tween the cells. Arteries and veins run through the sub-
arachnoid spaces with branches penetrating into the
parenchyma [23]. Veins leaving the parenchyma drain
into the various venous sinuses and thence to the jugu-
lar veins.
When considering fluid balance, the brain can be
thought of as a greatly distorted tube, sealed at one
end. Starting from the blind end, the spaces inside this
tube include (Figure 1a), a pair of lateral ventricles, one
in each cortical hemisphere, connected to a midline
third ventricle, which in turn is connected via the cere-
bral aqueduct (or aqueduct of Sylvius) to a midline
fourth ventricle that leads to both the central spinal
canal and, via foramina of Magendie and Luschka, to
the subarachnoid spaces outside the tube. All of these
spaces including the central canal and the subarachnoid
space of the spinal cord are filled with CSF. Because
the skull is a rigid box, the sum of the volumes occu-
pied by the parenchyma with its ISF and associated
connective tissue, the vasculature, the meninges and
the CSF must be constant, a concept known as the
Monro-Kellie dogma [24] which has implications for
CSF movements during the cardiac cycle, see below.
The spinal cord has the same components but less rigid
constraints on its total volume [6].
Table 1 Comparison of composition of CSF and blood
plasma
Component Ref. CSF Blood plasma
Concentration/mg (100 ml)-1
Protein a 16 to 38 6300 to 8500
Sugar a 45 to 80 80 to 120
Amino acids a 1.5 to 3 4.5 to 9
Creatinine a 0.5 to 2.2 0.7 to 2
Uric acid a 0.4 to 2.8 2.9 to 6.9
Urea a 5 to 39 22 to 42
Cholesterol a trace 100 to 150
Lactic acid a 8 to 25 10 to 32
Phosphate (inorganic) b 3.4 4.7
Concentration/mmol kg-1
Na+ b 147 150
K+ b 2.86 4.63
Ca2+ b 1.14 2.35
Mg2+ b 1.1 0.8
Cl− b 113 99
HCO−3 b 23.3 26.8
pH b 7.3 7.4
Values are taken from the compilations in a) Millen and Woollam (1962) [2]
based on data from Merritt and Fremont-Smith (1937) [31] and b) Davson and
Segal (1996) [9].
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The ISF provides the environment within which the
brain cells survive and function. Water and solutes enter
and leave the cells from and to this fluid. As such its
composition and volume must be controlled to allow re-
producible and reliable cell activity. There must be
mechanisms for rapid delivery of both oxygen and nutri-
ents, especially glucose and possibly lactate but also
amino acids and other substances. There must also be
mechanisms for rapid removal of the principal waste
products, especially carbon dioxide and possibly lactate.
These requirements are met by having microvessels
within the parenchyma sufficiently close to all cells that
diffusion distances for these solutes are small. Regulation
of Na+, K+, Cl−, Ca2+, Mg2+, HCO−3 and other ion con-
centrations in the ISF is important for correct nervous
activity and regulation of the sum total of the solute
concentrations, the osmolality of ISF, is crucial for regu-
lation of cell volume.
The CSF serves a number of functions which include
providing a) partial buoyancy for the brain, cushioning it
within its rigid box, b) a means to compensate for the
changes in blood volume within the skull during the car-
diac cycle and c) a route for removal of waste products
from the brain, particularly those of high molecular weight.
CSF is also important in removing protein and other deb-
ris during recovery from injury or microhemorrhage. It
may also serve as a route for dispersal of certain nutrients
and hormones and other molecular signals which may be
particularly important in brain development [25].1.4 Composition of fluids
CSF and ISF are very similar in composition. K+, Ca2+, Na+
and Cl− concentrations in ISF have been determined dir-
ectly using ion selective microelectrodes [26,27]. They have
also been inferred from the modest changes in compos-
ition of CSF measured as it flows over the surface of the
brain exchanging components with ISF [6,9,28,29]. The
composition of ISF and of CSF does, however, differ
significantly from that of blood plasma (Table 1). This is
because many hydrophilic substances are effectively pre-
vented from entering the brain from the blood and many
substances, including neurotransmitters, are greatly hin-
dered in exiting from the brain (e.g. [6,30]). The barriers
preventing these movements include the blood-brain bar-
rier separating blood and ISF within the parenchyma and
the blood-CSF barriers comprising the choroid plexuses
and the arachnoid and dura that surround the brain
(Figure 1).1.5 Anatomical basis of barriers and routes of fluid transfer
The blood-brain barrier (Figure 2a) is formed primarily
by the layer of endothelial cells lining the microvesselswithin the brain parenchyma [32,33]. These cells are
joined to each other via tight junctions that effectively
block free passage of molecules and ions between cells
across the endothelial layer, i.e. the paracellular route.
Substances required to enter or leave the brain across
the barrier must of necessity be transferred through the
cells. They must either pass through the lipid portions of
the plasma membranes, if they are not too hydrophilic,
or be transferred via specific transporters (e.g. GLUT1
for glucose) located on each side of the cells.
The CSF-containing spaces are bounded by: the arach-
noid membrane on the outside surface of the subarach-
noid spaces, the pia mater on the inner surface of those
spaces, the ependyma lining the ventricles and the chor-
oid plexuses. The arachnoid membrane consists of one
or more layers of cells connected by tight junctions [36]
and these layers are presumed to be the basis for the
impermeability of the arachnoid membrane (see [9] for
further discussion). The choroid plexuses (Figure 2b)
consist of a layer of epithelial cells facing ventricular
CSF and overlying permeable capillaries of the fenes-
trated type. The barrier separating CSF from blood is
provided by the epithelial layer rather than the under-
lying capillary endothelium [37]. The cells of the chor-
oidal epithelium are sealed together by tight junctions
that limit paracellular movement of most materials be-


























Figure 2 Key features of a) blood-brain barrier and b) choroid plexus. a) Sketch based on electron micrographs [34] of brain microvessel
walls showing endothelial cells linked by tight junctions. These cells form a complete lining of the microvessel lumen and are in turn surrounded
by glial end-feet. Occasional pericytes embedded in the basement membrane that separates the endothelial cells and the end-feet are not
shown. The tight junctions limit the transport of solutes between the endothelial cells but the basement membrane, the gaps between the glial
end-feet and the extracellular spaces within the parenchyma allow passage of molecules as big as proteins. Mitochondria occupy up to 10 % of
the endothelial cell volume [35] and provide a substantial source of energy for transport. b) Diagram of one side of a choroid plexus villus as seen
in light micrographs (e.g. [2]). Note the 100-fold difference in scales. Each choroid plexus has many such villi, each consisting of a layer of
epithelial cells linked by tight junctions and surrounding a core of connective tissue containing capillaries. The endothelial cell layer lining these
capillaries is not sealed by tight junctions. The epithelial cells have a prominent apical brush border facing the ventricle and a band of tight
junctions separating the apical and basolateral domains of the cell membrane. There is folding of the basolateral membranes, which like the
individual microvilli of the brush border are not visible in light micrographs (for electron micrographs see Figures two & twelve in [15]). The microvilli
and basolateral folds increase the surface area of the membrane domains and hence the number of transporters that can be located on the two sides
of the cells. Choroid plexus epithelium has the structure and properties of a leaky epithelium capable of transporting large quantities of isosmotic fluid.
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ies between ISF and CSF. The inner surfaces of the paren-
chyma facing the ventricles (Figure 1b) are lined with
ependymal cells, which do not appear to possess tight
junctions that would provide a barrier such that even
substances as large as inulin can pass between them
[12,32,38-40]. Nevertheless loss of inulin or albumin from
ventricular CSF into ISF is slow (at least in the absence of
oedema), simply because diffusion of large molecules is
slow and there is almost no convection. The outer surfaces
of the brain parenchyma, defined by the glia limitans and
the pia mater (Figure 1c), also do not provide a barrier to
the movement of water and small solutes (section 4.1.1.1).
Albumin injected into the parenchyma is slowly cleared
from the ISF: some of it reaching CSF and some trans-
ported back to blood via other routes (section 4.1). The in-
terfaces and routes of transfer important in production,
circulation and removal of ISF and CSF are indicated sche-
matically in Figure 3. An overriding principle is that what
goes in must come out. An important way to address
the rates of formation of CSF and ISF is to measure theirrates of removal and this has been the subject of much
investigation.
There is abundant evidence that much, probably most,
of the CSF is formed by secretion by the choroid plexuses
that are located in the brain ventricles, but the importance
of ISF from the brain parenchyma as a source of CSF re-
mains controversial. The principal sites at which CSF
leaves the CNS are currently thought to include [16] the
arachnoid villi linking cranial subarachnoid spaces to low
pressure venous sinuses, the cribriform plate through
which pass the olfactory nerves, and arachnoid villi located
at the origins of the spinal nerves (Figure 1a).2 Basic principles of fluid movements in the brain
and lessons from studies on peripheral tissues
In gaining a better understanding of how ISF and CSF are
formed and removed, it is necessary to consider a number
of basic principles: not least, the distinctions between dif-
fusion and bulk flow/convection and between filtration and
secretion. Some aspects of these issues particularly as they
choroid 
plexuses 






















Figure 3 Schematic plan of the whole brain indicating the fluid
movements considered in this review. Fluid is secreted into the
ventricles across the choroid plexuses (1) and into the brain parenchyma
across the blood-brain barrier (2). Fluid components can move through
the parenchyma (3) and there are exchanges of water and solutes
(4) and (5) between the interstitial fluid (ISF) of the parenchyma and
cerebrospinal fluid (CSF) contained in the ventricles and in the
subarachnoid spaces respectively. There is net fluid outflow across the
arachnoid villi (6) leading to the dural venous sinuses (including but not
restricted to the superior sagittal sinus) and along cranial nerves, most
notably the olfactory nerve leading to the cribriform plate (7) and thence
to the nasal mucosa. There may also be outflow of fluid in the walls of
arteries or veins (8) leading to lymph nodes in the neck. The traditional
view of the directions of net CSF flow is indicated by the dotted lines
with arrowheads.
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cently by Wolak and Thorne [41].
2.1 Diffusion
Diffusion is the observable movement of substances re-
sulting from their random thermal motions. For a neutral
solute in a stationary fluid, diffusion occurs down a con-
centration gradient. For ions, diffusion occurs down the
resultant of the concentration and electrical gradients.
For solutes crossing a lipid membrane, diffusion is best
thought of as occurring down the gradient of electrochem-
ical potential, defined in thermodynamics to include effects
of differences in concentration, pressure and electrical po-
tential. Diffusion occurs because all molecules are con-
stantly in motion colliding and exchanging energy with
their neighbours. For a neutral solute in a fluid, these ran-
dom movements can generate net movement of the solute
simply because there will be more solute molecules mov-
ing away from regions with high concentrations than there
will be solute molecules moving away from regions with
low concentrations. In a dilute solution, the movement of
each solute molecule is independent of the movements ofthe others: there is no co-operativity. Because more
massive particles have lower velocities, the rate of diffusion
decreases as the mass of the solute increases. Diffusion is
very fast over very short, atomic distances but because it is
a random walk of short jumps with frequent changes of
direction it is very slow over large distances.
2.2 Bulk flow or convection
Bulk flow, otherwise termed convection, is the movement
of a fluid where all components of the fluid tend to move
together. For example in a river the water and all it carries
moves by bulk flow. In pure bulk flow, movements against
the flow can be ignored. Furthermore all components irre-
spective of their size within a small volume of the fluid,
providing it is sufficiently far from all boundaries, will
move at the same speed.
2.3 Instances and relative importance of diffusion and
bulk flow
When considering transport through extracellular fluid,
cytoplasm or even the interior of a lipid bilayer, diffusion
is the dominant process over short distances, i.e. less than
a few microns and sometimes up to a few millimeters pro-
vided a concentration gradient exists. Bulk flow is the
dominant process when transfers occur over long dis-
tances. Examples of diffusive movements include transfer
of oxygen across a cell membrane and transfer of water
across a lipid bilayer [42]. An example of bulk flow is
blood flowing through the vasculature.
In most instances the actual process is neither just dif-
fusion nor just bulk flow but something intermediate. A
single process is actually occurring but it is often con-
venient to describe it as the sum of a movement due to
diffusion superimposed on a movement due to flow of
the fluid as a whole. Partly to emphasize that move-
ments against the flow cannot be ignored, the flow com-
ponent is often called convection rather than bulk flow.
Though convection is difficult to avoid in an uncon-
fined space (even small differences in density resulting
from differences in temperature are sufficient to produce
eddies) large forces are required for flow to occur in
confined spaces. This is illustrated by Poiseuille’s equa-
tion showing that the pressure difference required, ΔP,
to produce a flow, QV, through a tube with internal ra-
dius, r, increases with the inverse fourth power of the
radius,
ΔP ¼ constant QV
r4
It is this strong dependence on the size of the spaces
available for flow which accounts for the very high re-
sistance to flow through the interstitial matrix normally
found between cells, but the more than 1000-fold lower
resistance to flow in the same tissues when the matrix is
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peripheral tissues appears to be vested in the nature of
the gel within the interstitial spaces rather than the sizes
of the spaces themselves. It has been estimated that in
synovium [45] which has an extracellular space of about
20 % (within the range associated with grey matter in
the brain [9,46]) the actual resistance is about 5000-fold
greater than if the spaces were filled with free fluid.
2.4 Transfers by specific transporters
In addition to diffusion or convection, transfer across
membranes can often involve interactions with specific
transporters, which include channels (e.g. Kv1.3 for K+);
cotransporters (e.g. NBCe1 for Na+ and HCO−3 ) and ex-
changers (e.g. AE2 for Cl− and HCO−3 ). Cotransporters
and exchangers are examples of carriers. A more compli-
cated carrier, the Na+, K+-ATPase couples the energy re-
leased by hydrolysis of ATP to force Na+ and K+ to move
against their gradients of concentration and electrical po-
tential. For that reason this type of transporter is often
called a pump. The Na+-pump is the key link between en-
ergy released from metabolism and the secretion processes
in the choroid plexuses and at the blood-brain barrier.
2.5 Filtration, secretion and absorption
Net movement of fluid across barriers can be described
as filtration or secretion. Either process in reverse is
called absorption.
2.5.1 Filtration
Filtration is the production of a net volume flow across
a barrier driven by hydrostatic pressure and/or osmotic
pressure gradients. The energy source for the movement
of water and solutes comes from outside the barrier, not
from the processes occurring within the barrier.
Filtration across the walls of capillaries is often de-
scribed using the language of non-equilibrium or irre-
versible thermodynamics. In this the net volume flow
per unit area, the volume flux, is given by:





where Lp is the hydraulic permeability, ΔP the hydro-
static pressure difference across the membrane, R the
universal gas constant, T the absolute temperature, Δci
the concentration difference for the ith solute (e.g. Na+,
Cl−, or serum albumin) and σi the corresponding reflec-
tion coefficient [47-49]. The reflection coefficient for a
particular solute and a particular membrane is usually
defined as the ratio of the osmotic pressure difference
produced by that solute across that membrane to the os-
motic pressure difference that would result if the solute
were totally impermeant [47,49]. The name “reflectioncoefficient” stems from its appearance in another equa-
tion from the same theory that applies when there are
no solute gradients and the fluxes are driven solely by a
hydrostatic pressure difference,
J i ¼ ci 1−σ ið ÞJV
where Ji is the flux of the ith solute present on both
sides at concentration ci. Thus if all of the solute is
reflected σi = 1 and there is no flux of solute, while if
none is reflected σi = 0 and the solute is transferred
along with the water. One of the main results of the ap-
plication of non-equilibrium thermodynamics to mem-
brane transport is that the reflection coefficients are the
same in the two equations given above [47,48]. These
equations come with two caveats: they have a firm basis
only when the forces and flows are small enough that
each flow is a linear function of the individual forces
[50] and strictly the concentration differences should be
differences in thermodynamic activities, which is import-
ant in quantitative work as the osmotic pressure of the
proteins deviates markedly from the ideal value calcu-
lated from van’t Hoff ’s law, Δπ = RTΔc.
The Starling mechanism is a special case of filtration
that accounts for fluid movement across the walls of
peripheral capillaries. Starling [51] divided the solutes
present in plasma and extracellular fluid at osmotically
important concentrations into two groups: small mole-
cules, the crystalloids like Na+, Cl− and glucose, which
can easily cross peripheral microvessel walls, and all the
rest, the colloids, like serum albumin which cross very
slowly. Using this distinction he proposed that fluid
movement across microvessel walls can be described as
net filtration or reabsorption of a fluid composed of
water and crystalloids driven by the differences of the
hydrostatic pressure and the osmotic pressure of the
colloids. The latter has been called variously the colloid
osmotic pressure or the oncotic pressure. Starling’s
simplifications of the actual process cannot describe
short-term transients when for instance the plasma NaCl
concentration is abruptly changed but have otherwise
been remarkably successful in describing fluid move-
ments into and out of peripheral tissues (e.g. [49,52,53],
see Endnotea).
In the language of non-equilibrium thermodynamics,
Starling’s approximation amounts to saying that σi is 1 for
the colloids and σiΔci approaches zero for all of the crys-
talloids. It has proven very difficult to determine the values
of σi for small solutes and peripheral microvessels because
permeation is so fast that equilibration between plasma
and the interstitial fluid immediately outside the microves-
sels is reached during the measurement, i.e. Δci ≈ 0 [54].
The “true reflection coefficients” may be much greater
No net fllux 
a) 




Figure 4 Fluxes inwards or outwards across a membrane
compared with net flux. The membranes are indicated by the grey
bars. In a) and b) the magnitudes of the fluxes are very different but in
both cases the fluxes in the two directions are equal and hence there is
no net flux. In c) and d) the magnitudes of the fluxes in the two
directions are very different and there is a net flux in the direction
indicated by the black arrow. Although the flux from left to right is the
same in a) and c), because the fluxes in the opposite direction are not
the same there is a net flux in c) but not in a). Hence net flux cannot be
inferred from measurements of flux in a single direction.
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0.1, often quoted (for discussion see e.g. [54-56]).
2.5.1.1 Mechanistic descriptions of filtration The treat-
ment of filtration using irreversible thermodynamics
assumes that the energy sources for filtration are the
hydrostatic and concentration gradients. It makes no at-
tempt to elucidate the actual mechanisms involved other
than to stipulate that they must explain the values of Lp
and σi. Attempts at mechanistic descriptions have been
complex and controversial and none has achieved wide-
spread acceptance. For discussion of some of the difficul-
ties see e.g. [53,57,58]. Bulat and Klarica [59], alongside
their consideration of brain fluid movements, have pro-
posed that in peripheral capillaries water moves down the
resultant of the hydrostatic and total osmotic gradients
and that the resulting change in total osmotic pressure ra-
ther than the colloid osmotic pressure within plasma limits
the water fluxes and thus filtration. However, their pro-
posal ignores the effect of Na+ and Cl− fluxes across the
peripheral capillary walls that reduce the local solute con-
centration differences. In its present state this description
is not an improvement on the Starling approximation.
2.5.2 Secretion and absorption
Secretion of fluid is a net volume flow into a region of
interest, driven by energy derived from metabolism within
a barrier (e.g. [5]). The energy is supplied as part of the
transport of solutes; the water follows osmotically but see
e.g. [60,61] for consideration of the possibility of specific
active water transport. Absorption or reabsorption of fluid
could in principle be either filtration (including non-
selective filtration, i.e. bulk flow) or secretion of fluid each
directed back towards the blood. At least part of the ab-
sorption of CSF may be a non-selective flow of fluid carry-
ing all its components through the arachnoid villi or the
cribriform plate.
2.6 Uses of tracers or marker substances and lessons from
the periphery
Following the movement of tagged substances, i.e. tracers,
has been a common method both for determining the
characteristics of flow of the various brain fluids and for
investigating transport processes across the choroid plex-
uses and the blood-brain barrier. The nature of the
particular tracer used is crucial in the interpretation of re-
sults. For instance to measure flow, the marker must move
only because there is net flow, must move at the same rate
as the flow and must be easily detected quantitatively.
Such markers have included inulin, dextrans and serum
albumin. Other markers such as India ink particles and
horseradish peroxidase have been very useful for tracing
routes, but not for determining rates of flow. Tritiated
water is not suitable for measuring rates of bulk flowbecause it is not constrained to stay within the fluid for
which flow is being measured. (A well-known example is
the flow of fluid through a capillary as described below).
Furthermore, additions of tritiated water on just one or
the other side of a barrier cannot be used to measure se-
cretion or absorption because water moves so rapidly in
both directions by diffusion. Net flow across a barrier oc-
curs only if the fluxes of water and solutes in one direction
exceed those in the other direction (Figure 4). It is possible
for there to be large tracer fluxes while not having net
flow. In that case the fluxes in the two directions are equal
in magnitude.
To illustrate the importance of distinguishing the flux
in one direction from net flux, one can consider the net
flux of water across peripheral capillaries and venules of
e.g. skin or muscle. The net flow can be determined by
measuring water content, volume or weight changes in
the tissues since almost all of the fluid is water. The re-
sult for non-fenestrated peripheral capillaries, which has
stood the test of time, is that the net rate of filtration
into the tissue is of the order of 0.1 % of the blood flow
[62]. This filtration is driven by the Starling balance of
forces, i.e. the net result of hydrostatic and colloid os-
motic pressure differences (section 2.5.1). This net driv-
ing force can be expressed as a pressure difference or,
using Δπ = RTΔc with RT = 19 mmHg/mM, as the con-
centration or osmolality difference Δc that would pro-
duce the same osmotic pressure, i.e. 19 mmHg is
equivalent to 1 mM. The net driving force is very small,
reduced by local concentration gradients in the regions
of flow.
The water fluxes into and out of a tissue can be deter-
mined using radiotracers or heavy water. These fluxes
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than the net rate of filtration of water. Virtually all of
the tritiated water molecules delivered by the blood
cross the capillary wall before the blood leaves the tissue
and thus transfer is limited by blood flow [55,63,64].
How is it that the net flux of tritiated water appears so
large while the net flux of water is so small? The meas-
urable net flux of tritiated water is driven by its own
concentration gradient, which on a first pass through a
tissue means effectively by its concentration in plasma
since the concentration in the much larger volume of
the tissue remains very small, i.e. the influx of tritiated
water is almost equal to the net flux of tritiated water.
Since, near enough, tritiated water and normal water be-
have the same, this means that influx of water, the in-
ward unidirectional flux (Endnoteb), is driven by its total
concentration, approximately 55 M. However, the net
flux of water, the filtration, which can be measured by
volume change, is the difference between the influx and
an almost equal efflux and thus it is driven by an equiva-
lent concentration difference of water, which across a
peripheral capillary wall is approximately 1 mM. Because
the driving forces are so different, 55 M vs. 1 mM, it
should not be surprising that the unidirectional flux is
much larger than the net flux. Similar comparisons can
be made for Na+ [55,63,64]. The molecular mechanisms
for movements of Na+ and water across the walls of per-
ipheral microvessels look more like diffusion than flow,
but nevertheless the net process is still filtration. The
traditional [52] and current [49,53] views on filtration
and reabsorption in peripheral capillaries are described
briefly in Endnotec.
It is important to keep in mind that the terms filtration
or reabsorption each describe a net process. They do not
describe the movements in a single direction. No one now
describes the process of fluid movement in peripheral ca-
pillaries as filtration of 99.9 % into the tissue with reabsorp-
tion of 99.8 % leaving 0.1 % in the tissue to be removed in
the lymph flow. The difficulty is not with the numbers, as
these are approximately the proportions of water mole-
cules that move, but with the use of the words. These
points are clear in the application of the principles to
microvessels in the periphery. However, there are repeated
instances of reports concerning fluid movements in the
brain that have not been careful to distinguish between
tracer fluxes and net fluxes of water and hence have incor-
rectly identified rates of secretion, filtration, absorption or
flow of CSF and ISF (e.g. [65-72]).
2.7 Application of basic principles to blood vessels in the
brain
The same physical chemistry applies to brain microves-
sels as to peripheral capillaries, but there are important
differences in the barrier properties of the vessel wallsand in the transport pathways across them (Figure 5). In
the periphery Na+ and Cl− cross the capillary walls easily
in both directions and except possibly during relatively
brief transients, e.g. when osmotic gradients are artifi-
cially imposed, their concentrations in the filtrate are
similar to those in plasma. By contrast, at the blood-
brain barrier, the low resistance pathways shared by
water and hydrophilic solutes are absent, i.e. the para-
cellular route is blocked by tight-junctions. The blood-
brain barrier has at least a 10 fold lower permeability to
net flow of water than peripheral capillaries but the
fluxes of water are still large enough that ca. 90 % of
tracer water is extracted from the blood in a single pass
[73-75]. Thus movements of water can occur relatively
easily when gradients of total osmolality are imposed.
Osmotic equilibrium is approached on a time scale of a
few minutes [76-78] but equilibration half-times mea-
sured at various locations within the brain vary, presum-
ably reflecting differences in the ratio of the surface area
of microvessels to the local tissue volume [78]. Osmotic-
ally driven movement of water is the basis of the clinical
use of hyperosmotic mannitol in plasma to draw water
out of the brain to relieve elevated intracranial pressure.
Net water movements in response to imposed osmotic
differences are properly called filtration or absorption
depending on the direction. They can be described (as in
section 2.5.1) as flow driven by the resultant of hydro-
static and total osmotic pressures. This is not the same
as the Starling mechanism concerned with fluxes of
water and all small solutes across peripheral membranes.
Starling’s approximations only work when small solutes
permeate rapidly (section 2.5) and this is not the case
for the blood-brain barrier.
The permeability of brain microvessels to Na+ and Cl−
is more than 1000-fold lower than that of peripheral
microvessels and the reflection coefficients of these and
many other small solutes, e.g. sucrose and raffinose, are
indistinguishable from 1 [7,73]. This has very important
implications for the “normal” movements of water and
solutes in the absence of imposed osmotic differences.
Any filtration driven by a difference in hydrostatic pres-
sure will contain very little solute (section 2.5.1). Because
even a small, e.g. 1 mM, concentration difference for NaCl
across the barrier represents the same driving force as an
unphysiologically large, e.g. 38 mmHg (= 56 cmH2O),
hydrostatic pressure difference, the rates of water and
solute transport must be closely matched. Any possible
increase in hydrostatic pressure difference will only
produce a small flow of water that becomes self-
limiting because it will reduce the osmolality in the
interstitium. Furthermore net reabsorption of fluid
driven by hydrostatic or colloid osmotic pressure
gradients must leave the solutes behind and thus the
reabsorption will be self-limiting. It can at most be
b) cerebral 
microvessels
Water passes through and 
between the cells. 
  Small solutes follow 
passively between the cells 
staying close to osmotic 
equilibrium.  
  Net movement is down the 
resultant of hydrostatic and 
colloid osmotic pressure 
differences  (i.e.                 
for all the small solutes is 
much smaller than               
for the colloids). 
Water passes through the 
cells down the resultant of 
the hydrostatic and total
osmotic pressures. 
  Solutes are secreted 
across the cells.  
  Because hydrostatic 
pressure differences are 
small, and water is still 
relatively permeant, solute 
movements dictate net 
movement of water (i.e. 
water movement proceeds 
so that                 for all 
solutes stays close to 









Figure 5 Comparisons of fluid transport across peripheral and cerebral microvessels. In the periphery a) small solutes cross the vessel
walls via gaps between the cells. Small solute movement is rapid, therefore their concentration gradients are small and thus unlike the large
solutes, the colloids, the small solutes do not oppose the movements of water. Thus except during brief transients, e.g. when osmotic gradients
are artificially imposed, net fluid movement is governed by the hydrostatic and colloid osmotic pressure differences between blood and
surrounding tissues. In the brain b) paracellular movement is limited by tight junctions. Thus small solutes cross the vessel walls only slowly and
the direction and extent of their movement is determined by specific transporters. Hence they are as effective as the large solutes in producing
osmotic gradients that dictate the extent of water movement into or out of the surrounding tissue.
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produced.
Viewed the other way round, net solute transport
across the blood-brain barrier will be matched by water
flow. In other words, water follows salt. One could say
that solutes are actively transported across the blood-
brain barrier and water follows by filtration but the con-
vention is to refer to the entire process as secretion of
fluid. This has the important advantage that it empha-
sizes that the energy driving the process is derived from
metabolism within the blood-brain barrier not from ap-
plied pressure gradients. The rate of secretion of fluid
across the blood-brain barrier is determined by the net
rate of solute transport. Furthermore, so long as water
can move sufficiently rapidly between plasma and ISF
that the osmolalities of these fluids are approximatelyequal, the volume of ISF in the brain is determined by
the solute content of the ISF and the osmolality of the
plasma.
Reabsorption across the brain microvessels of paren-
chymal fluid derived from the CSF has been proposed
repeatedly [11,65-70,79-84] but in no instance have these
proposals included a mechanism for reabsorption of the
solutes. As explained above, the net pressures that can
be produced, colloid osmotic or hydrostatic cannot drive
net removal of fluid across the intact blood-brain barrier
at a rate capable of dealing with excess fluid brought
into the brain parenchyma (section 4.2.2 and Endnoted).
This is not a new idea; this inability of the intact blood-
brain barrier to reabsorb interstitial fluid has been ar-
gued before by many others [5,7,85-87]. Reabsorption
could occur if the blood-brain barrier were to become
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barrier failure and would mean it could no longer con-
trol ISF composition. The reason that removal of fluid
across the intact blood-brain barrier cannot match the
rate at which fluid is produced is that there is no mech-
anism for net transport of NaCl across the barrier in the
direction from brain to blood. If salt could be trans-
ported, then water would follow.
The rate of secretion of Na+, Cl− and HCO−3 is the pri-
mary determinant of the rate of fluid secretion into the
parenchyma. Metabolically-produced water does not
affect these rates and hence has little impact on fluid se-
cretion [88]. The water derived from metabolism will ei-
ther be absorbed across the blood-brain barrier or
reduce the amount of water needed to accompany the
secretion of solutes by the blood-brain barrier.2.8 Diffusion and convection within the parenchyma
By analogy with peripheral tissues (section 2.3), the ex-
pectation is that movements of water and solutes in brain
ISF will be primarily by diffusion rather than convection.
Thus diffusion is the mechanism for movement of mole-
cules between adjacent cells. On the distance scale of ca-
pillary to parenchymal cell for which estimates range from
10 μm to 50 μm [89-92] the dominant process still clearly
is diffusion and this accounts for the important move-
ments of O2, CO2, glucose and lactate. The sole exception
may be local circulation of K+ accompanied by water, a
story tied up with the idea of glial K+ buffering which is
beyond the remit of this review. For distances up to a
millimeter or more, diffusion still appears to be the most
important process but additionally there is convection
along fibre tracts in white matter [93] and other privileged
pathways, which may include capillary basement mem-
branes and the perivascular spaces along arteries and
veins. These privileged routes will be considered in sec-
tion 4. The evidence that diffusion is the dominant process
within grey matter is considered immediately below. More
extensive reviews of this subject and related matters are
available [41,46,94-96].
The early studies on transport within the extracellular
spaces of the parenchyma were aimed primarily at dem-
onstrating that these spaces exist, a hot issue in the early
1960s. These studies were based on measured concen-
tration profiles within the parenchyma of radiolabelled
solutes chosen for their inability to enter cells or cross
the blood-brain barrier [97,98]. At various times after
the labelled solutes were added to the ventricles (and
kept at constant concentration by perfusion), the ani-
mals were killed, and parenchymal samples were taken
at known distances from the ventricular surface. The
concentration of solute found in the tissue adjacent to
the perfused surface provided a measure of the volumeoccupied by the extracellular space while deeper samples
provided information about diffusion. These values were
then compared with those expected theoretically if









where C(x) is the concentration at distance x, C0 is the
concentration at the ventricular surface, t is the time after
addition of the solute, D is the effective diffusion coeffi-
cient and erfc is the complementary error function.
Hindrance to diffusion imposed by the tissue is described
by the tortuosity, defined as the square root of the ratio
D0/D, where D0 is the diffusion coefficient in a free
medium. The comparison of experiment and theory pro-
vides two tests of whether or not solute movement is by
diffusion by asking: “Do the data fit the shape of the theor-
etical curve?” and “Is the value calculated for the diffusion
constant the same for different times?” It was found that
the data obtained by this method pass both of these tests.
However, Rall [38] has stated quoting C.S. Patlak that
these tests could still be passed even if there were convec-
tion with a flow towards and across the ependyma of up
to 1/4 of the CSF production into the ventricles. In other
words the data do not exclude convection that has been
inferred from experiments on efflux of test substances
from the parenchyma (section 4.1).
More recent determinations of transport through intersti-
tial spaces have been based on injection or iontophoresis of
a test substance at a point in the parenchyma and detection
in real-time of its spread through the tissue. In the Real
Time Iontophoresis method using tetramethylammonium
ions (TMA), these cations are iontophoresed from a micro-
electrode and their concentration measured a known dis-
tance away with an ion-selective microelectrode [95,99].
This technique can be calibrated to give actual concentra-
tions resulting from known amounts of TMA added in a
very small region and enables both volume fraction and tor-
tuosity to be calculated. In the Integrative Optical Imaging
method, a fluorescent marker is pressure injected and the
concentration profile determined from microscopic obser-
vation of the fluorescence as a function of position in the
surroundings. This is more difficult to calibrate and only
yields a measure of the effective diffusion coefficient and
tortuosity for the marker, but it has the advantage that it al-
lows checks on the symmetry of the spread away from the
injection site [46,95,100]. For instance it can show that
spread in white matter occurs preferentially parallel to the
long fibres. The large amounts of data obtained using these
techniques are consistent with diffusion as the mechanism
of transport over short distances. Flow velocities around
10 μm min-1, as inferred from tracer studies of solute flux
(section 4.1 and [93]) would be too small to change
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parameters (Charles Nicholson and Tony Gardner-
Medwin, personal communications) and even the larger
flows inferred from some more recent measurements (see
caveats in section 4.1.1) may be difficult to detect.
Convection may be more important as a mechanism for
fluid movement in the brain under conditions where there
is oedema associated with expanded extracellular spaces as
can occur in white matter. By analogy with peripheral tis-
sues, the resistance to convection may then be much
smaller than in non-oedematous tissue (section 2.3). Reulen
et al. [101-103] have considered convection in some detail
in connection with the spread and resolution of oedema.
Convection is important in the spread of drugs injected
into the parenchyma in comparatively large volumes, so
called convection-enhanced drug delivery [104-106] al-
though the extent to which the flow passes through the
interstitial spaces between cells in grey matter rather than
being restricted to privileged pathways such as perivascular
spaces has apparently not been determined.
2.9 Secretion by the choroid plexuses and the blood-
brain barrier
The reader interested in the now historical argument
about whether transport across the choroid plexus is se-
cretion or filtration should consult reviews by Cserr [4],
Davson and Segal [9] and Damkier et al. [15]. As discussed
by Damkier et al. [15] the choroid plexus has all the hall-
marks of a high capacity secretory epithelium whose prod-
uct is isosmotic with plasma. The blood-brain barrier is a
barrier at least partly because the endothelial cells lining
the microvessels lack the low resistance paracellular path-
ways for small solutes that characterize microvessels in
peripheral tissues (Figure 5). Instead the endothelial cells
are sealed together by tight junctions that prevent (or at
least greatly reduce) the passage of markers like horserad-
ish peroxidase and lanthanum [32,34] and raise the elec-
trical resistance to levels similar to those in tight epithelia
[107,108]. As discussed in section 2.7, this low paracellular
permeability means that sustained net movement of fluid
across the blood-brain barrier requires transport of solutes
to generate an osmotic gradient. Water then follows,
partly by simple diffusion across the membranes of the
endothelial cells, but possibly also via various transporters
[61,109]. The mechanisms of ion transport at the blood-
brain barrier have been reviewed by O’Donnell [18] and
will be considered further in a sequel to this review.
3 Formation and removal of CSF and ISF
3.1 CSF
In 1996 when Davson and Segal published their monu-
mental review [9] the general view was that the rate of
production of CSF was roughly 400 ml/day in humans
and that of this perhaps 90 % arose as secretion by thechoroid plexuses and 10 % by secretion of ISF across the
blood-brain barrier and subsequent flow to join CSF.
However, both the underlying assumption that all ISF
flows into the CSF and the relative contribution of ISF
to the secreted CSF have been and remain controversial.
3.1.1 Formation of CSF
If the choroid plexuses produce almost all the CSF, their
removal should prevent the excessive fluid accumulation
in the ventricles that occurs in hydrocephalus (section 4.2).
Yet Milhorat [110-112] has stated quite firmly that
choroidectomy does not work for the treatment of
hydrocephalus and thus there must be sources of CSF
in addition to the choroid plexuses. However, at least in
the hands of Scarff [113], choroidectomy was found to
be an effective therapy in a large proportion of patients
with communicating hydrocephalus. One possible ex-
planation of these discrepancies may be the extent to
which total choroidectomy had been achieved. Regard-
less of the eventual resolution of the dispute over clin-
ical utility, taking Milhorat’s and Scarff ’s work together
leaves little doubt of the basic physiological point, i.e.
removal of the choroid plexuses reduces the rate of pro-
duction of CSF but to nowhere near zero. The extensive
series of choroid plexus cauterization treatments for
hydrocephalus in children by Warf [114,115] (see also
[116]) is consistent with the choroid plexuses being a
major, but not sole source of CSF even in children
under one year (compare section 4.2.3).
3.1.2 Removal of CSF
As reviewed by Pollay [16,117], CSF is removed by several
routes including the arachnoid villi leading to venous si-
nuses, perineural pathways across the cribriform plate lead-
ing to nasal mucosa, and pathways at the roots of spinal
nerves leading either to blood or lymph [8,9,118-127].
Large solutes like albumin that are removed from the brain
via the cribriform plate enter lymph. By contrast, a large
proportion of the lower molecular weight solutes and water
leaving by the same route reach the blood directly across
peripheral capillary walls in the nasal mucosa [120]. The
relative rates at which CSF is removed by the various
routes may vary markedly between species.
3.1.3 Measurement of CSF production rate
CSF production rate has been measured in several ways
[9] of which three will be discussed here. These are a) col-
lecting CSF as fast as it is formed; b) recording the rate of
removal of injected markers into CSF; and c) measuring
the dilution of markers perfused into the ventricles at a
known rate. In the collection method a), CSF is removed
through tubing or a needle held at a pressure sufficiently
low that CSF exits solely by this route, it being assumed
that all normal exit routes require a higher pressure. This
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[128,129]. Caveat: It is no longer clear that this procedure
can prevent exit of fluid from the brain by other routes.
There may be large variations in the rate at which sub-
stances reach differing parts of the subarachnoid space
when infused into the ventricles [130,131]. Furthermore as
discussed in section 4.1, it appears that some of the fluid
secreted into the ISF in the forebrain returns to blood or
lymph by routes that avoid mixing with CSF in the cis-
terna magna indicating that not all regions of the sub-
arachnoid spaces are in free communication [119,132].
These observations suggest that reducing pressure at the
point of collection, e.g. cisterna magna or lumbar sac, may
lead to collapse of part of the subarachnoid space and thus
failure to transmit the reduction in pressure to other parts.
Collecting CSF from some portions of the subarachnoid
space may be a bit like trying to suck fluid through a
flimsy straw. In the marker removal method b), a marker
substance is injected into the cisterna magna and a
complete collection of CSF is made at some later time.
The rate of loss of the marker and the CSF production
rate are calculated from the amount remaining. The calcu-
lation requires the assumption that CSF is well mixed
throughout the period before collection and that all of the
CSF can be collected. The method would still work if a
portion of the CSF e.g. that in the spinal cord, were com-
pletely stagnant and were not reached by the marker and
were not collected. Caveat: Studies such as those dis-
cussed in sections 4.1 and 4.3 indicate that CSF is not well
mixed as required for these calculations. In the perfusion
method c), fluid containing a known concentration of a
marker is infused at a constant rate into a lateral ventricle
and fluid is sampled by withdrawal from either the cis-
terna magna or lumbar sac. Assuming that the marker
only leaves the CSF as part of fluid with the same concen-
tration as in the sample, i.e. by bulk flow of well mixed
CSF, and all of the secreted CSF is added to the mixture
that is sampled, the secretion rate can be calculated as
follows [133]:
secretion rate ¼ perfusion rate
 Cperfusate − Ccollected
Ccollected
where each C is the concentration in the indicated fluid.
Note that this method does not require total collection
of CSF and thus the sample can be small and can, at
least in principle, be taken without reducing intracranial
pressure. Caveats: If CSF were secreted solely from
blood into the ventricles from which it flowed into the
cisterna magna and was then reabsorbed into blood or
lymph from the subarachnoid spaces, the assumptions
needed for this calculation to be correct would be plaus-
ible. However, as will be discussed in section 4, these arenot safe assumptions. CSF is not well mixed and, as a
result, the marker concentration in the sample does not
accurately reflect those in the various outflows. At
present there can be no “gold standard” method for
measuring CSF production at least partly because there
is no single compelling definition of what CSF produc-
tion means, e.g. rate of fluid secretion into the ventricles
or alternatively rate of fluid secretion into the CNS as a
whole. The present estimates are likely to be reasonable
values for the normal rate of secretion of fluid into the
ventricles but may be underestimates of the total rate of
fluid secretion into the brain as discussed in the follow-
ing sections.
3.2 Measurement of ISF production rate
Estimates of the rate of ISF production can at least in
principle be obtained from measurements of a) the rate
of CSF production after destruction or removal of the
choroid plexuses [134,135], b) the rate of entry of fluid
into the perfused cerebral aqueduct [136,137] and most
convincingly c) the rate of removal of markers injected
into the parenchyma [132,138,139]. Caveats: There are
drawbacks to each of these approaches. As Milhorat
[112] was careful to emphasize, the first a) requires total
removal of the choroid plexuses (or evidence about the
contribution of the portions remaining) and measures a
rate of fluid production after the fluid dynamics have
been severely altered. The second method b) requires
the assumption that ISF production in regions that drain
towards the aqueduct is typical of production in all
regions. In addition, the measurements are made after
extensive recent surgical intervention. The third method
c) requires that measurements be made in a number of
locations (cf. [139,140]) and assumes that the tracer sub-
stance is carried out of the parenchyma by convection,
that there is no sieving of the markers and that the flow
arises only by secretion of fluid across the blood-brain
barrier.
Sieving refers to the retardation of movement for large
solutes when fluid flows through a filter, a matrix or a
gel. Flow through a matrix does not lead to flow of sol-
utes of all sizes at the same rate, a defining characteristic
of pure bulk flow, unless the sizes are all well below the
typical distance between the fibres of the matrix [141].
The nature of the matrix, if any, along the rate limiting
portions of the flow pathway for drainage of interstitial
fluid (see section 4.1) is unknown. Thus estimating fluid
flow rate from the rate at which large markers are re-
moved from the tissue may underestimate the net rate
of flow of water and small solutes. The evidence for bulk
flow and for the absence of sieving in the parenchyma
for solutes smaller than albumin is that the measured
rates of removal of tracers of a range of sizes up to albu-
min were all the same [132]. However, the rate limiting
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ways including perivascular (or Virchow-Robin) spaces,
spaces between fibre tracts in white matter and spaces
within the subependymal layer of the ventricles [7,138].
The evidence obtained from removal of large markers is
considered further in section 4.1 and the assumption
that flow through the parenchyma arises only from the
blood-brain barrier is considered in sections 4.3 and 5.
4 Ongoing approaches to the investigation of
brain fluid dynamics
4.1 Studies of movement of substances and routes of
outflow from the brain parenchyma
To discover whether the production of ISF contributes
to the CSF, it is necessary to find out whether ISF drains
into CSF before leaving the brain or whether it goes via
some independent route. As described below, drainage
of ISF appears to be partly to CSF as sampled in the cis-
terna magna and partly to cervical lymph nodes by routes
that do not require the emerging ISF to mix with CSF in
the cisterna magna.
4.1.1 Periarterial spaces as routes of efflux
When markers such as radiolabelled serum albumin or
polyethylene glycols are injected into the caudate nu-
cleus of one side of the forebrain, twice as much appears
in the ipsilateral cervical lymph node as in the contralat-
eral node in the neck, and less than 30 % reaches the cis-
terna magna [119,132]. By contrast, if the same markers
are injected into ventricular CSF a smaller proportion ap-
pears in the cervical lymph nodes but that which does so
appears symmetrically on the two sides. These results
have since been extended to other sites of injection re-
vealing that the fraction of tracer reaching the cisterna
magna varies depending on distance from the injection
site [139,140]. Furthermore, in experiments following the
clearance of radiolabeled albumin, tracer concentration
was found to be much higher in the walls of dissected ar-
teries supplying the region where the tracer had been
injected than in the surrounding CSF. For the caudate
nucleus and internal capsule this prominently included
the circle of Willis. Similarly, when horseradish peroxid-
ase was injected (in the large volume of 30 μl) into the
midbrain of a rat, it could be detected an hour later in or
on the walls of branches of the posterior cerebral artery
[139]. These findings were confirmed and extended [140]
with the additional observation that the delay between
the disappearance of tracer from the site of injection and
its appearance in lymph was longer when the tracer was
injected into the parenchyma than into CSF. Caveats:
Two features of these studies have been challenged: the
overall rate of removal and the assumption that injection
of marker does not disturb the routes of outflow being
examined. These experiments were all performed usingbarbiturate anaesthesia, but it has subsequently been
shown that the half-life for efflux of 14C-sucrose, which
crosses the blood-brain barrier at a negligible rate, is
about 4 h when the rats are awake or anaesthetized with
ketamine and xylazine but about 25 h when they
are anaesthetized with pentobarbital [142]. In ketamine/
xylazine anaesthetized mice efflux of mannitol, another
solute with low blood-brain barrier permeability, has a
half-life similar to 4 h [143]: this confirms the result for
sucrose. If the half-life for efflux of albumin is similarly
faster in awake animals than in those anaesthetized with
barbiturates, the estimates of the ISF production rate
given by Cserr and co-workers [132,138,139] may need
to be revised upwards, perhaps by as much as 6-fold (but
see section 4.3 for alternative explanations for rapid re-
moval of solutes). The rate of efflux of albumin clearly
needs to be investigated further with attention being
given to the state of anaesthesia.
Another serious concern is raised by the suggestion that
the rates of infusion or volumes injected may have been
sufficient to alter the mechanisms and routes of elimin-
ation. Iliff et al. [143] suggested that the observation of ef-
flux along arteries might represent an artefact of “high
local intraparenchymal pressure from the injection”.
Pressure-induced flow is used in convection-enhanced
drug delivery [105]. However, even the lower end of the
infusion rates employed, 0.5 μl min-1 to 20 μl min-1, is 8-
fold larger than the rate, 0.5 μl infused over 8 min, used by
Szentistvanyi et al. [139]. Thus it is difficult to see how the
infusions in the reported studies could have altered the
efflux route from a putative physiological perivenous route
(section 4.3) to the periarterial route observed.
Bradbury, Cserr and colleagues were of the opinion that
flow out of the parenchyma occurred along periarterial
spaces [144] and that where the arteries reached the sub-
arachnoid space there was some form of barrier separating
the periarterial and subarachnoid spaces. Of the structures
described subsequently by Zhang et al. [23,145] (Figure 1d)
this barrier may be the sheath of pia mater enveloping the
artery. Cserr and Patlak and Bradbury et al. incorporated
this route of efflux into a general scheme in which ISF is
secreted by the blood-brain barrier and then flows out of
the parenchyma to CSF via periarterial spaces. The pial
barrier delays but does not prevent passage of the albumin
into CSF destined for the ipsilateral side of the cribriform
plate and thus to the nasal mucosa [8,119].
Further evidence supporting the existence of periarterial
spaces as routes of efflux from the parenchyma has been
provided using two-photon microscopy together with 3
kDa cascade blue dextran, viewing being through a cranial
window [146]. Following injection into the parenchyma,
the marker was detected in a space surrounding the arteries
and in the extracellular matrix of the arterial smooth
muscle layer but not along veins. The authors state (data
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similar for 3 kDa and 70 kDa markers but no removal was
seen for a 2000 kDa marker. Fluorescence decreased more
rapidly in the interstitium and periarterial space than in
the smooth muscle layer. The authors suggest that this is
because there are multiple routes for removal from the
interstitium but only one for the smooth muscle layer. An
alternative explanation for these observations may be that
the dextran binds within the extracellular matrix of the
smooth muscle layer.
4.1.1.1 Evaluation of the proposal that periarterial
spaces provide an efflux route for markers The idea
that markers can move from the parenchyma via convec-
tion in periarterial spaces (Figure 6) and thence transfer
into CSF has a number of plausible features. The convec-
tion inherent in this idea would always occur along path-
ways that should have a low resistance to flow. Similarly,
transfer to and from CSF across the pial barrier should
be rapid for small solutes [97,143,147-153] (but see
section 4.3.1). It is slow, but still easily demonstrable, for
macromolecules [32,138,143,154]. The actual permeabil-
ities for transport between CSF and parenchyma across
the pia mater are not known because concentrations on
both sides of the barrier have not been measured simul-
taneously. Some of the large solutes emerging from the
parenchyma not only reach CSF but also find their way
to the cisterna magna [119,132]. This scheme suggests a















Figure 6 Diagram indicating positions within the cortical parenchyma
shown correspond to those around the arteries in Figure 1d. The diagram
versions [1]. The diagram (not to scale) shows: the tunica intima, the endot
media, a smooth muscle layer; and the tunica adventitia, mainly connective
inner, called the periarterial space by Zhang et al. [23] and labelled the inn
space of the subarachnoid portion of the same artery. The outer that in co
His [1]. In the view of Weller and associates (personal communication) both
with no thickness and fluid movement occurs preferentially in the extracell
spaces are considered in section 4.3.4.proportion of substance reaching the cisterna magna is
larger from injection sites that are closer to the cisterna
magna.
Rapid inflow via a periarterial space may also partly ac-
count for the early observation that horseradish peroxidase
injected into CSF reaches the basement membranes of
even the small microvessels in the cortex within a few mi-
nutes [79,154-156] but at low concentration, such that at
early times only very sensitive detection methods are cap-
able of establishing its presence [157]. Rapid appearance of
low concentrations deep in the cortex is the behaviour ex-
pected for relatively rapid transport over the large distance
(millimeters) from the cortical surface, provided this is pre-
ceded or followed by slow penetration through a barrier.
The rapid transport along the periarterial spaces could be
provided by stirring or mixing in the perivascular spaces
driven by the arterial pulse (compare [143,154,156,158]).
The barrier could be the pial coating of the arteries, which
would precede the rapid transport process, or it might be
the basement membranes or the layer of glial end-feet as-
sociated with the microvessels, either of which would fol-
low the rapid process. There does not appear to be any
data relating to the mechanism of transport for horseradish
peroxidase through the subarachnoid space (section 4.3).
Whether veins also constitute an exit route for injected
albumin from the parenchyma is not known. Most studies
have not looked at this aspect, but in their fluorescent
marker studies, Arbel-Ornath et al. [146] examined arter-










of periarterial spaces that may allow fluid movement. The spaces
has been formatted so that it may be compared with earlier published
helial lining of the lumen and a covering of elastic tissue; the tunica
tissue. Within these layers there are two possible free spaces. The
er periarterial space in the diagram, is continuous with the periarterial
ntact with the brain parenchyma, is likely to be the space described by
the inner periarterial space and the space of His are virtual spaces
ular spaces of the smooth muscle layer. Other interpretations of the
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periarterial spaces, CSF and the cribriform plate is an
attractive proposal, it nevertheless raises a number of
questions:
1. Can albumin be detected in sufficient concentrations
near the cribriform plate for the nasal route to be
able to account for the removal of the markers?
Does obstruction of the cribriform plate reduce
transfer of markers injected into the parenchyma to
cervical lymph nodes as it does [120] for markers
injected into CSF (see also [159,160])?
2. Why have some markers (section 4.1.2) been
difficult to detect in the periarterial spaces? The
present lack of such data in images of brain sections
(e.g. [161]) is perhaps to be expected for two
reasons: as the spaces are thought to have rapidly
changing dimensions they may collapse during
sample preparation and the concentrations in these
spaces during efflux of markers may be low
(section 4.3 for further discussion).
3. Does the use of barbiturate anaesthesia alter the
routes of efflux as well as reducing the rate
(section 4.1.1)?
4.1.2 Extracellular spaces of the arterial smooth muscle
layer as routes of efflux
Weller, Carare and colleagues have been pursuing an al-
ternative hypothesis that flow out of the parenchyma oc-
curs through the smooth muscle layer of the arterial
walls (Figure 6). They have shown that fluorescently
tagged 3-kDa dextran, 40-kDa ovalbumin and amyloid-β
[153,161-163] injected into the parenchyma become dif-
fusely spread and associated with both the basement
membranes of capillaries and the extracellular spaces
separating the smooth muscle cells in arterial walls. Five
minutes after injection into the parenchyma they found
markers associated with the basement membranes. For
tissue fixed after 30 min, the markers were still present
diffusely in the parenchyma and were also found in the
smooth muscle layer, but not within capillary basement
membranes. For fixation after 3 h (for the dextran) or
24 h (for all markers), fluorescence was seen only in
punctate form near the outside edges of the walls of
arteries associated with macrophages. These data were
interpreted as supporting clearance of the markers from
the interstitium via bulk flow through microvascular
basement membranes and the extracellular spaces be-
tween the smooth muscle cells of arterial walls [161].
Caveats: It is clear that markers can reach the extra-
cellular spaces of the smooth muscle layer of the arteries
from the parenchyma, but it is not clear that there can
be significant flow along these layers. However, it would
be unwise to dismiss movement via the smooth musclelayer as physically impossible without evidence. The data
raise a number of questions.
1. Why have the fluorescent markers investigated been
concentrated in basement membranes and the
smooth muscle layer? Is there some form of
association or binding? Is there a sieving effect with
retention of larger solutes with higher flow of water
and smaller solutes than suggested by the movement
of the markers?
2. Can there be exchange between extracellular spaces
of the arterial smooth muscle layer and nearby
periarterial spaces? If so, efflux from the parenchyma
might be via the periarterial spaces with the marker
able to gain access to the smooth muscle from the
adjacent periarterial space.
3. Why are the fluorescent markers not found within
the endothelial basement membranes of the arteries
or within the outer basement membrane of the
arterial wall [161,164]?
4. Why does fluorescent ovalbumin disappear from the
capillary basement membranes while there is still
diffuse fluorescence observed in the surrounding
parenchyma [161]?
5. What is the driving force for flow along arterial
walls? Is it, as suggested, the arterial pulse changing
compression in the wall [161,165]? Is there any
structural basis for the “valves” which appear to be
needed to make compression drive movement
preferentially in the outward direction [165,166]?
6. Can movement of markers along arteries from
parenchyma to lymph node be measured? How long
does it take for them to reach the subarachnoid
space and subsequently the cervical lymph nodes?
7. What fraction of an injected load of marker can be
accounted for by that moving along arteries and
reaching cervical lymph nodes?
8. Does deposition of amyloid-β along presumed flow
pathways obstruct fluid movement via these same
pathways? What happens to water and small
solutes?
9. How in earlier experiments did radiolabelled human
serum albumin injected into the parenchyma
[119,132,139,140] reach CSF in the cisterna magna
(see earlier discussion)?
Even if the smooth muscle layer of arterial walls is
not the main route for fluid transfer, it may still be
important in clearance of amyloid-β and other pro-
teins. This aspect has been the emphasis of recent
work, e.g. [164,167,168]. It should be noted that the
periarterial routes for transfer discussed in sec-
tion 4.1.1 and in this section and indicated in Figure 6
are not mutually exclusive. It is possible that all
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also conceivable that net flow is in opposite directions
in different spaces or even in both directions at differ-
ent times within one. These possibilities are consid-
ered further in section 4.3.4.
4.2 Studies of CSF flow and the implications of the flow
patterns for sites and rates of production and absorption
of CSF and ISF
4.2.1.1 Measurement of CSF flow by phase contrast
magnetic resonance imaging (PC-MRI) Interest in pat-
terns of CSF flow and what they reveal about the sites and
rates of production and absorption of CSF have been
rekindled by results obtained using PC-MRI and in par-
ticular measuring CSF flow through the cerebral aqueduct
that connects the third and fourth ventricles. The develop-
ment of PC-MRI has allowed real-time monitoring of
blood flow in arteries and veins and, under favourable cir-
cumstances, also flow of CSF. MRI detects the magnetic
dipoles of hydrogen atoms in small regions, called voxels,
each of the order of 1 mm3. Application of this technique
is more difficult for measuring CSF movements than for
measuring blood flow because CSF movement is slower
and the regions of interest are often small, containing only
a few voxels. Despite these limitations, results of PC-MRI
have provided useful information about CSF flow.
4.2.1.2 Cyclic variations in CSF flow From the results
of PC-MRI and other techniques it is apparent that CSF
flow in the cerebral aqueduct is not steady but rather
varies over the cardiac cycle, driven by changes in blood
volume in the brain vasculature [169]. In systole, more
blood flows into the brain through arteries than leaves
via veins while in diastole the reverse is true. Thus blood
volume in the brain varies over the cardiac cycle and,
because the skull is rigid and the inside volume is fixed,
something else must compensate and this is achieved by
shifting CSF from brain to spinal cord during systole
and back during diastole. In normal people and experi-
mental animals, a small part of this shift is movement of
CSF in and out of the lateral and third ventricles via the
cerebral aqueduct. Peak flow rates in each direction
through the aqueduct of a normal subject are typically
10 times larger than the net average flow over the entire
period. These fluid movements assist in mixing CSF in
the ventricles and subarachnoid space.
4.2.1.3 Direction of net flow Early PC-MRI results for
normal subjects were interpreted as yielding calculated
net flows through the aqueduct consistent with values
of CSF production rate in the ventricles determined
by other means [169-173]. However, later studies have
challenged the traditional view that CSF is producedprimarily in the ventricles and absorbed primarily in lo-
cations distant from the ventricles.
4.2.2 Changes in flow in hydrocephalus
Even before PC-MRI results became available there were
reports showing that the standard story of a constant rate
of CSF production in the ventricles and net flow from lat-
eral and third ventricles outwards towards the subarach-
noid space was not correct in patients with hydrocephalus,
a condition where there is abnormal enlargement of the
fluid-filled ventricles.
4.2.2.1 Non-communicating hydrocephalus In patients
with non-communicating hydrocephalus the normal exit
route for CSF from the ventricles, the cerebral aqueduct,
is blocked. In these patients the rate of increase in ven-
tricular volume has been reported to be far less than the
normal rate of CSF production [174] and this can be
reproduced in animal models. Some even contend that, at
least in the cat, blockage of the aqueduct produces no ven-
tricular swelling at all [175,176]. Set against these reports
must be experimental results (for an early example see e.g.
[177]) and clinical experience (e.g. [135]) indicating that
blockage does produce ventricular swelling. Milhorat et al.
[178] tested this explicitly in monkeys by inflating a bal-
loon in the fourth ventricle so blocking the aqueduct.
Swelling of the lateral and third ventricles was seen to be
initially rapid, possibly corresponding to the normal rate
of production of CSF, but then to become less rapid. Three
alternative explanations may be considered for why the
rate of swelling following blockage of the aqueduct can
be substantially less than that generally believed to be
the “normal” CSF production rate: firstly secretion of CSF
may have become inhibited; secondly blockage may not
have been achieved; and lastly alternative routes for re-
moval of CSF from ventricles may have been created or
become important. Agreement has been reached [5,9] that
the CSF production rate does not change or at least does
not change enough to explain the above result (e.g. [179]
and for an early study see [174]). Change of CSF produc-
tion rate will not be considered further here. Possible al-
ternative routes for fluid escape will be considered in
section 4.2.4.
4.2.2.2 Communicating hydrocephalus and the
possibility of reverse net flow In communicating hydro-
cephalus, there is no impediment to CSF movement be-
tween ventricles and cisterna magna but there is still
marked ventricular enlargement (by definition) and usu-
ally subarachnoid space contraction. PC-MRI measure-
ments have shown greatly increased amplitudes of fluid
flow through the aqueduct during the cardiac cycle, e.g
6-fold larger than normal, presumably because more
CSF shifting from the cranium to the spinal cord must
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paring control subjects with patients with normal pres-
sure hydrocephalus, found net flow in the expected
direction and of the expected magnitude [180]. Some
studies reporting large peak flows in each direction did
not calculate a net flow [170,181,182] but there are now
a number of reports of calculated net flows in the
reverse direction, i.e. from fourth to third ventricle
[69,83,84,172,183,184].
Suggestions of reverse net flow through the cerebral
aqueduct in communicating hydrocephalus predate evi-
dence from PC-MRI. Milhorat summarizing early results
concluded (p139 in [135]) “In communicating hydroceph-
alus the normal subarachnoid pathways are obstructed
and the subarachnoid flow is frequently reversed and di-
rected into the ventricular system. … Diagnostically, retro-
grade filling of the ventricular system is a characteristic
cisternographic finding in communicating hydrocephalus”.
James and colleagues injected radiolabelled albumin
into the cisterna magna of both dogs and monkeys with
experimentally-induced communicating hydrocephalus
and were able to see accumulation of the marker in the
ventricles and periventricular regions, implying there must
be net flow of fluid in the reversed direction, i.e. into the
ventricles [185-188]. Such reverse net flow through the
aqueduct implies both a major route for exit of CSF from
the lateral and third ventricles other than the aqueduct
and a major source of CSF other than the choroid plex-
uses (Figure 7). One proposal for an additional source is















Figure 7 View of net CSF flow pattern in normal adult brain compare
normal adult, most of the CSF is secreted by the choroid-plexuses and is re
to the nasal mucosa. There is modest secretion across the blood-brain barr
net flow through the cerebral aqueduct is from the third ventricle towards th
of reverse net flow through the aqueduct implies that formation of CSF occur
across the blood-brain barrier into the cortex and thence out into the CSF-co
CSF from the third and lateral ventricles. This route must accommodate both
entering the third ventricle via the aqueduct. Possible routes are discussed in
from Strazielle et al. with permission [19]).brain barrier. Candidates for the route of outflow are less
obvious. In conjunction with the ventricular enlargement
there is periventricular oedema in white matter, which
may allow abnormal routes for fluid removal from the
ventricles [86].4.2.3 CSF flow in infants
Reverse flow in the aqueduct has also been reported by
one group in children under two years; this being sug-
gested as the normal condition for this age group
[69,84,184]. There has also been a report of “early ven-
tricular reflux” of radiopharmaceuticals in children under
two years [189]. If net flow from fourth to third ventricle
is accepted, “from where does it come, to where does it
go” [69]? The blood-brain barrier can secrete fluid so
the suggestion that the choroid plexuses are not the
main source of CSF until two years is a hypothesis that
should be tested. However, no evidence using any tech-
nique other than PC-MRI has been presented that
would indicate a change in formation rate at or about
the age of two. Using an infusion technique to deter-
mine the relation between intracranial pressure and rate
of addition of fluid to CSF, Blomquist et al. found 588
ml/day as the control rate of CSF production, with no
clear variation in age from two months to about ten
years of age [190]. This is towards the high end of esti-
mates of the normal adult rate. There is greater diffi-
culty in understanding the fate of the CSF as discussed
below.?









 via cribriform plate?
reduced outflow via
arachnoid villi?
d with that proposed for communicating hydrocephalus. a) In the
absorbed through the arachnoid villi or via the cribriform plate leading
ier into ISF most of which emerges into CSF across brain surfaces. The
e fourth ventricle. b) In communicating hydrocephalus, the observation
s outside of the ventricles, probably by more extensive fluid secretion
ntaining spaces. Reverse net flow also requires some route for removal of
fluid secreted by the choroid plexuses located in these ventricles and fluid
section 4.2.4. (The background image is the same as in Figure one-a taken
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ventricles
If net flow of CSF through the aqueduct is towards the lat-
eral and third ventricles, then where does CSF leave these
ventricles? Three possibilities need to be considered: a)
there is another conduit for outward flow; b) CSF passes
into parenchyma where it mixes with ISF and finally enters
microvessels, i.e. it crosses the blood-brain barrier; and c)
CSF flows into the parenchyma, mixes with ISF, and finally
exits by other routes as discussed in section 4.1.
a) Possible alternatives to the cerebral aqueduct as a
conduit for flow of CSF out of the central ventricles
have been discussed by Ghersi-Egea, Nagaraja,
Fenstermacher and colleagues [130,131]. These
putative conduits are in regions where there is only a
thin wall separating the ventricles from subarachnoid
space [3]. However, there has been little support from
any other groups for the idea that these regions do
provide a pathway for flow. Nevertheless a search for
such a conduit would be appropriate as there could be
benefits from its presence as is seen in the treatment
of hydrocephalus when an outflow route is produced
surgically by third ventriculostomy (e.g. [114]). A
further alternative route proposed by Milhorat [191]
for flow out of the ventricles in hydrocephalic infants
is via the choroid plexuses. This would require net
flow to occur across the epithelium towards the blood,
possibly via the paracellular route. However, Wislocki
and Putnam found no movement of dyes via the
choroid plexus in hydrocephalus induced by injection
of lamp black into the cisterna magna [192] and
Eisenberg, McLennan and Welch [193] found in
kaolin-induced hydrocephalus that there was no
reabsorption of fluid from the ventricles and thus
perforce none via the choroid plexuses. However,
Welch and Sadler had earlier found free diffusion of
solutes as large as inulin from ventricles to blood but
at a low rate as if across only a small fraction of the
area of the choroid plexuses [194]. There was also an
additional component of transport as if ventricular
fluid were being moved across the choroid plexus by
pinocytosis. The rate at which fluid was transferred by
this route was later estimated to be at about 1/10th
the normal rate of secretion [5]. In summary, while
the balance of evidence is against a role for the
choroid plexuses in net flow from ventricle to blood,
the idea has not been conclusively excluded and
requires further investigation.
b) With regard to the second possible exit route for
CSF, as already discussed in section 2.7, CSF
absorption by penetration into the parenchyma and
subsequent absorption into brain capillaries driven
by colloid osmotic or hydrostatic pressures cannotbe sustained for more than a few minutes so long as
the blood-brain barrier is intact. It seems unlikely
that this route is important for infants because there
is no evidence of a major difference in the properties
of their blood-brain barrier compared to older chil-
dren. In hydrocephalus, alteration of the blood-brain
barrier should be considered, but no evidence
appears to have been produced that such alteration
provides a route for the net removal of fluid from
regions of the parenchyma. Linninger et al. [82] and
Penn et al. [83] concluded that the blood-brain
barrier was an important site of fluid removal from
the parenchyma, but while their analysis supports
the conclusion that there is some route of removal,
the conclusion that this route is across the blood-
brain barrier is the result of circular logic as their
model for fluid movement considered only the
blood-brain barrier as a possibility.
c) Large scale flows of water in and out of parenchyma
can be produced osmotically (section 2.7) and large
fluid flows can also occur in regions of oedema. Thus
in hydrocephalus, where there is periventricular
oedema in white matter, it may well be the case that
there are pathways for flow through the brain to
alternative routes of exit such as those considered in
section 4.1. Such a flow of fluid from ventricles into
the parenchyma and thence to perivascular spaces
was proposed as early as 1921 by Wislocki and
Putnam [192]. By contrast, flow of the magnitude
proposed through non-oedematous parenchyma from
ventricles to the subarachnoid space would be without
precedent. But “without precedent” only means that
more direct evidence is required before the idea can
be accepted.
Irrespective of the ultimate site of reabsorption of the
fluid, if there is a marked increase in fluid transfer through
the parenchyma there should be a marked change in the
fate of markers injected into it. These are experiments that
need to be done.
4.2.5 Caveats on PC-MRI results for net flow through the
aqueduct
The idea that in communicating hydrocephalus and in
infants there is a cortical source of CSF and a sink
for fluid in the ventricles via the parenchyma (or pos-
sibly the choroid plexuses) is based primarily on the
validity of results for reverse net flow in the aqueduct.
There are a number of features in the PC-MRI exper-
iments, usually interpreted using proprietary software,
which may not have been adequately tested and/or
calibrated (for a recent review see [182]). Here are
some of the pitfalls.
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artificially controlled environments (so called
“phantom” models) and they can detect time-
dependent arterial blood flow with considerable
accuracy as shown in both the brain and heart.
However, it is not always clear that reported
measurements have been calibrated under conditions
appropriate to oscillatory CSF flow in the aqueduct
(e.g. see [195] for discussion of some precautions).
2. To detect the slow flow in a small structure such as
the cerebral aqueduct it is necessary to subtract the
signals derived from a region that is thought to be
stationary. Comparison of Bateman’s results with
and without subtraction [84,184] indicates that the
subtraction is crucial. Is it sufficiently accurate?
Note that it may not be possible to find a stationary
region as the brain parenchyma moves in synchrony
with the cardiac cycle [169,196]. In any case, there is
likely to be a net blood flow in an otherwise
stationary region [197].
3. To calculate CSF flow from CSF velocity data obtained
by PC-MRI, it is necessary to make assumptions about
the flow profile across the aqueduct and/or to have
enough voxels entirely within the aqueduct to calculate
an adequate average. It has also been assumed that the
cross-sectional profile of the aqueduct remains
constant through the cardiac cycle. The available
evidence suggests the calculations are sufficiently
accurate for peak flows in both directions, but are they
sufficiently accurate to calculate the smaller average
over the entire cycle, i.e. the net flow?
4. The voxels to be included in the calculation of flow
must be selected; a process which when automated
is called segmentation. Has this process been
sufficiently robust [173,182]?
Calculating net flows from large flows in opposite direc-
tions suffers from the classic problem of subtracting large
numbers to determine small differences; the signal can eas-
ily get lost in the noise. Experimentally there are large vari-
ations in the values of the net flows reported by various
groups. Before the idea that reverse net flow occurs is fi-
nally accepted the reasons for these variations/discrepan-
cies need to be better understood. At present the results for
children are suggestive but not compelling. In communicat-
ing hydrocephalus the results from PC-MRI are supported
by those from other techniques, notably cisternography
and quantitative autoradiography [187,198] which show
that in these patients, but not in normal subjects, there is
movement of radiolabelled albumin from cisterna magna
to ventricles with accumulation in the ventricles and/or
periventricular tissue. Furthermore in both communicating
and non-communicating hydrocephalus there is oedema
in the parenchyma adjacent to the ventricles, which mayreduce resistance to fluid flow into the tissue from the ven-
tricles. This might provide a route of fluid movement ul-
timately either to CSF in the subarachnoid space and
thence to blood or lymph or more directly to sites outside
the skull via perivascular or perineural spaces (section 4.1).
It is also possible that the hydrocephalic state is associated
with damage to or alterations in the properties of the
blood-brain barrier or the choroid plexuses. There is a real
need for experiments in which results from PC-MRI and
from other techniques are compared directly in the same
animals or patients.
4.3 Recent studies on perivascular routes for entry into
and exit from the cortex
Proposals that substances enter and leave the parenchyma
via perivascular spaces are as old as studies on the forma-
tion and absorption of brain extracellular fluids. Some as-
pects have been considered in earlier sections and earlier
work has been reviewed elsewhere [9,10]. It is clear that
substances can move via vascular-associated routes. This
section considers recent evidence obtained in rats and
mice that has led to the well-publicised (e.g. [199] and
[200]) glymphatic circulation proposal [201]: “ … CSF
passes through the para-arterial space that surrounds ar-
teries … and into the interstitial space … vectorial con-
vective fluxes drive waste products away from the arteries
and toward the veins. ISF and its constituents then enter
the para-venous space. As ISF exits the brain through the
paravenous route, it reaches lymphatic vessels in the neck,
and eventually returns its contents to the systemic
circulation”.
4.3.1 The basis of the glymphatic circulation proposal:
evidence from fluorescence imaging studies
Routes of transfer within mouse brain have been charac-
terized by Iliff et al. using imaging of a number of different
fluorescent markers [143]. For events near the cortical sur-
face they used two-photon microscopy through a cranial
window. For events occurring more than about 200 μm
below the surface, movements were inferred from fluores-
cence imaging of brain sections. Iliff et al. found that when
the 3 kDa labelled dextran, TR-d3, was included in closed-
circuit ventriculo-cisternal perfusion of mice, it penetrated
slowly into the parenchyma consistent with diffusion, just
as expected from earlier results (section 2.8). By contrast
when injected into the cisterna magna allowing access to
the subarachnoid space, it distributed quickly to the cor-
tical surfaces of the brain and within thirty minutes was
seen prominently along the course of the arteries penetrat-
ing the cortex and also within the interstitium. Likewise
45 kDa ovalbumin-647, OA-647, also injected into the cis-
terna magna, followed the arteries to the region of obser-
vation and into the cortex but was not seen in the
interstitium until later. Within the cortex, it was seen both
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layer of the arteries.
In a subsequent publication Iliff et al. emphasized that
when the 3 kDA TR-d3 but also larger markers, 40 kDa
dextran TR-d40 and 2000 kDa dextran FITC-d2000,
were injected into the cisterna magna they each reached
the region of observation along the walls of arteries
[202]. Initially, however, they were not seen within the
bulk of the CSF. The time-lapse images for TR-d40 (in
the supplementary material of [143]) show particularly
clearly that this marker followed the track of the arteries
within the subarachnoid space but then spread out from
these into the CSF. Such movement along arteries is
consistent with the data obtained using MRI [203]. The
route by which the markers gained access to the periar-
terial space from CSF in the subarachnoid cisternae is
not known [202,203]. The data show that the markers
travelled rapidly along the arteries but also that, at least
for markers of 45 kDa or less, they were able to move
between the periarterial space and CSF, a manoeuvre
which requires crossing the pial sheath (section 4.1).
The idea that injected materials become associated with
arterial walls has also been put forward by Rennels et al.
for horseradish peroxidase [154,156] and by Ghersi-
Egea, Nagaraja, Fenstermacher and colleagues for su-
crose [130,131]. This retention presumably indicates a
relatively low permeability of the pial sheath of the arter-
ies to sucrose.
Caveat: 10 μl is a large volume to infuse into the CSF of
a mouse and it is possible that the infusion may alter pres-
sures and flows with the brain. Iliff et al. [202] note that in
experiments under isoflurane anaesthesia, infusions like
those used in their earlier work [143,203,204] “resulted in
the non-physiological reflux of CSF tracer from the cister-
nal spaces into the fourth, third, and lateral ventricles” and
they showed that even infusion at 1 μl min-1 for 10 min
was associated with a temporary increase in intracranial
pressure (ICP). They concluded that “Given that rapid
paravascular CSF influx continues long after the nor-
malization of these shifts in ICP, the paravascular CSF
fluxes observed ....appear to represent physiological fluxes
and not artefacts of changes in ICP resulting from CSF
tracer infusion”. It is however conceivable that the in-
crease in pressure might produce changes that outlive the
increased pressure in the pial sheath of arteries traversing
the CSF cisterns or even in the pial sheath of arteries
within the cortex.
As found by Iliff et al. movement of fluorescent
markers from periarterial spaces into the parenchyma
depended upon their size [143]. Both 3 kDa TR-d3 and
45 kDa OA-647 spread into the parenchyma from both
the cortical surface and the periarterial spaces surround-
ing the penetrating arteries, but 2000 kDa FITC-d2000
did not appear to spread at all even though it was clearlyvisualized in the periarterial space. These fluorescence
data were not calibrated to allow quantitation of concen-
trations. However, from the comparison of the wide-
spread and prominent distribution of 3 kDa TR-d3 seen
using very sensitive fluorescence detection and the much
less widespread distribution of 1 kDa gadolinium-DTPA
detected using a less sensitive MRI-based method, Iliff
et al. concluded that the concentrations of both markers
in the parenchyma were much lower than those in the
periarterial space near the cortical surface [203]. It is dif-
ficult to be quantitative about the transfer process from
periarterial space to interstitium. In the case of TR-d3
the fluorescence signals from the periarterial regions
may be saturated and reveal little about the concentra-
tions while gadolinium-DTPA cannot be seen in the
parenchyma.
The above fluorescence and MRI data are consistent
with earlier findings concerning cortical penetration of
horseradish peroxidase [79,154-156] (cf. section 4.1) show-
ing very rapid delivery of small quantities of markers into
the parenchyma. From the speed of delivery over distances
of millimeters it is apparent that transport along periarter-
ial spaces cannot be just via diffusion (one point on which
all are agreed [157]), i.e. both earlier and current data pro-
vide strong evidence for a convective component to the
inward movement. These data are also consistent with
studies on access of drugs to the parenchyma from CSF
[158]. As reviewed by Papisov et al., the evidence shows
that drugs administered via the CSF are subject to “pulsa-
tion assisted translocation … into the perivascular space”
[205]. The fluorescence results of Iliff et al. confirm and
extend these findings and in addition, demonstrate that
along the cortical surface movement of markers appears
to be within a periarterial sheath, rather than just diffusely
through the subarachnoid space [143].
Having reached the parenchyma, OA-647 (45 kDa) was
seen in or on the walls of veins in the cortex 1 h but not
10 min after it was added to the cisterna magna. Iliff et al.
interpret this as showing that the marker leaves the paren-
chyma via the veins [143]. A similar time sequence has
been seen with another probe, rhod-2, consistent with this
idea of progression [206]. The observed sequence, near ar-
teries, near microvessels then near veins, is a major pillar
of the glymphatic circulation proposal: fluid flow inwards
along the arteries, then through the interstitium and
thence outwards along the veins [143].
4.3.2 Quantification of influx and efflux using radiotracers
Although fluorescence measurements are well suited for
identifying pathways and are the most sensitive detection
method that can be used in real time, they are difficult to
make quantitative. Radiotracers have also been used by
Iliff et al. to examine time courses for movement of














Figure 8 Effect of absence of AQP4 on fluid flow along
perivascular routes. In both a) the glymphatic circulation proposal
and b) the convection-assisted movement hypotheses described in
Figure 9, the absence of AQP4 results in reduced movement of fluid
from the periarterial spaces into the parenchyma (red arrow). In the
glymphatic circulation proposal this would produce a build-up of
fluid in the periarterial space, which would reduce flow into that
space and would also remove the source of fluid destined for perivenous
outflow. If instead, as in the convection-assisted movement hypotheses,
fluid flow can occur in both directions in the periarterial spaces with little
net flow, absence of AQP4 may not affect fluid flow along the periarterial
space, a result more consistent with the data. A indicates the periarterial
spaces, V the perivenous spaces. The question marks indicate that
convection-assisted movement may or may not also occur in the
perivenous spaces.
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terna magna and for retention of mannitol and amyloid
β1-40 injected into the parenchyma. Their uptake curves
for mannitol were interpreted as showing a single compo-
nent with half-time of about 15-20 min. Their time
course for retention of mannitol had a half-life of a
few hours, perhaps similar to the half-life of about 4
h found for sucrose by Groothuis et al. as discussed
in section 4.1. Caveats: by simple inspection of the
sample uptake traces of Iliff et al., it appears much
more likely that the uptake of mannitol has two com-
ponents, one very rapid, perhaps into the periarterial
spaces, and another much slower, possibly into the
parenchyma. Subsequent data reported for mannitol
by Xie et al., (supplementary material in [207]), con-
firm that there are at least two components of the up-
take. The earlier data comparing the uptakes of
mannitol and dextran-10 are not extensive enough to
allow any conclusion about the relative rates of up-
take.
4.3.3 Influences of aquaporin 4 (AQP4) located on astrocyte
end-feet on perivascular flow
It is interesting to consider how perivascular fluid move-
ment might be influenced by the presence of AQP4 lo-
cated on glial end-feet enveloping blood vessels within the
parenchyma [208]. Water and solutes moving between
perivascular spaces and parenchyma must either be trans-
ported into the end-feet or go through the narrow spaces
between them. AQP4 is abundantly expressed in the end-
foot membrane facing towards the vasculature and thus is
in a position to facilitate water transport via a transcellular
route. It was found in AQP4 knock-out mice that entry of
the smaller markers 3 kDa TR-d3 and 45 kDa OA-647
into the parenchyma from the periarterial space was
greatly slowed [143]. This was interpreted by Iliff et al. as
showing that by removing a pathway for water flow from
periarterial space into interstitium the rate of glymphatic
circulation was reduced. But reduction in glymphatic
circulation should involve not only penetration into
the parenchyma but also flow down the periarterial
space (Figure 8) and yet data from Iliff et al. for the
larger marker FITC-d2000 argues against such a re-
duction in periarterial convection: absence of AQP4
did not appear to affect penetration of the marker
deep into the periarterial spaces. Thus the observa-
tion that AQP4 knock-out reduces movement into
the parenchyma without reducing convection in the
periarterial space presents the glymphatic circulation
proposal with a substantial challenge. It indicates that
convection in some manner assists movement along
the periarterial spaces without producing a large net
flow in one direction.4.3.4 Reassessment of the evidence: alternatives to the
glymphatic proposal
Caveats: Although the glymphatic proposal provides a
basis for understanding much of the data, it does not ex-
plain the lack of effect of AQP4 knock-out on periarter-
ial flux of the large dextran TR-d2000 discussed in the
preceding section or the data for efflux via arterial routes
discussed in section 4.1. So, are there alternatives to the
glymphatic circulation proposal? In part, yes (Figure 9).
Convection in the periarterial spaces within the cortex
driven by cyclic changes in arterial pressure may pro-
duce either mixing (Figure 9b) or flows in opposite di-
rections in different spaces of the arterial wall (Figures 6
and 9c). In either of these alternatives, convection assists
movement into and out of the cortex without necessarily
producing the net flow of fluid into the cortex as re-
quired by the glymphatic circulation proposal (Figure 9a).
The back and forth periarterial convection resulting
from the cardiac cycle is rapid on a time scale of sec-
onds. Thus movement of a marker observed on a time


















Figure 9 Possible schemes to explain rapid influx of markers via
periarterial spaces: a) the glymphatic proposal based on Figure
five of Iliff et al. [143], b) stirring or mixing and c) layered flow.
In a) and c) there is preferential influx via the space between the arterial
wall and the pial sheath (the inner periarterial space in Figure 6) while in
b) convection back and forth, speeds up the rate of transfer of markers
in both directions. Red lines represent pial membranes, grey lines the
layer of glial end-feet or glia limitans, solid arrows are fluxes of markers
carried or assisted by convection, dashed arrows are either by diffusion
or assisted by convection and green arrows have been added as a
reminder that fluid secreted by the blood-brain barrier contributes to the
fluid in the parenchyma. The location of the pial barriers is based on
Zhang et al. [23] (Figures 1d and 6). In c) the influx of fluid via the
periarterial spaces may inflate the space of His providing a route for the
return of fluid to the subpial space at the cortical surface and then to
CSF in the subarachnoid space.
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movement down its concentration gradient.
Can the alternatives explain Iliff et al.’s data [143]?
The key observations are that when a marker was
injected into the cisterna magna it was seen to enter the
cortex along arteries and not veins whereas when the
same marker was injected into the parenchyma, it was
seen along veins but not arteries. These observations
could be explained by the alternative hypotheses in
terms of concentration differences and relative flow rates
along arteries and veins. As shown in Iliff et al.’s data in
the supplementary material [143] discussed earlier in
this section, a marker injected into the cisterna magna
would be delivered rapidly and at relatively high concen-
tration to the periarterial spaces at the cortical surface
but not the surrounding CSF or the perivenous spaces.
Hence movement of a marker into the cortex is bound
to be preferentially along arteries. By contrast when a
marker is added to the parenchyma, a significant frac-
tion of it might enter both perivenous and periarterial
pathways but with mixing or outward movement being
more effective in periarterial than in perivenous paths,
the marker would be removed more rapidly from the
periarterial spaces and the amounts seen there would be
less. Thus the observations with the fluorescent markers,
taken alone, can be rationalized. However neither the
glymphatic circulation proposal nor the convection-
assisted movement hypotheses can easily reconcile the
observation that the fluorescent markers are preferen-
tially located in perivenous spaces at late times with the
data for preferential periarterial location and efflux of
other markers discussed in section 4.1.
From both the more recent histological evidence
([23,144], Figure 1c) and from the functional evidence
discussed in sections 4.1 and 4.3, it can be concluded
that the spaces or pathways involved in periarterial flow
within the parenchyma are not in free communication
with CSF in the subarachnoid space but are separated
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separation is, however, challenged by the older observa-
tion that colloidal carbon gains access to a periarterial
space from subarachnoid CSF [1]. There would appear
to be three candidates for periarterial flow pathways
within cortical parenchyma (Figure 6). One is the extra-
cellular space in the smooth muscle layer as proposed by
Weller and Carare (section 4.1). Another is the space be-
tween the smooth muscle layer and the pial sheath
which Zhang et al. call the periarterial space [23] and is
probably the Virchow-Robin space of the older literature
(see [1] for discussion). The third is the space of His [1]
that may exist immediately adjacent to the glial end-feet.
Brinker et al. [17] label this outer space as the Virchow-
Robin space. Because the space of His is continuous with
the space below the pia mater at the cortical surface
(Figure 1c) it could be called the perivascular subpial
space.
It is tempting to speculate (see Figure 9c) that fluid ar-
riving within the pial sheath of arteries in the subarach-
noid space might be able to move inwards along the
(inner) periarterial space between the smooth muscle
and the sheath, much as proposed by Iliff, Nedergaard
and colleagues. However, rather than this fluid continu-
ing into the parenchyma (as in Figure 9a) it might inflate
the space of His (an outer periarterial space) allowing
fluid to return to the subpial space at the cortical surface
and thence cross the pia mater to the subarachnoid CSF.
The idea that the periarterial spaces may vary in calibre
depending on local pressures is inherent in the idea that
arterial pulsation drives convection. Such variability may
be part of the explanation of the observation by Iliff et
al. that there was far less inward movement of markers
when the dura was not intact [143].
The alternative hypotheses, based on mixing or layers of
flow as shown in Figure 9b and c, appear to explain the
fluorescence data at least qualitatively. Furthermore, unlike
the glymphatic circulation proposal, they can also accom-
modate the data considered in section 4.1 for periarterial ef-
flux of markers (though not simultaneously preferential
perivenous outflow of the fluorescent markers). The alter-
natives also provide an explanation for the lack of effect of
AQP4 knockout on the movements of large markers into
the periarterial space as they do not require net fluid move-
ment from the periarterial space into the parenchyma.
The two alternative hypotheses indicated and the glym-
phatic circulation proposal are not mutually exclusive and
furthermore there may be other scenarios. At present
there is conflicting evidence for outward flow along veins
and little evidence for net flow (as opposed to net marker
flux down a concentration gradient) inwards along arter-
ies. There is no evidence that the net flows, i.e. those in-
wards along the arteries, those proceeding through the
parenchyma and those going outwards along the veins areof similar magnitude as required by the glymphatic circu-
lation proposal. The implications of any of the schemes in
Figure 9 which bring fluid deep into the cortex and then
remove it, are that they would greatly shorten the diffusion
distance from CSF to points within the parenchyma and
hence the time taken for solutes to penetrate into or be
cleared from regions of the cortex. The principle of oper-
ation in 9b and 9c is the same as that of a microdialysis
probe which allows diffusional exchange between the
interstitial fluid and the fluid within the probe.
4.4 Studies concerning the influence of sleep and
anaesthesia on perivascular fluid flow and interstitial fluid
volume
The glymphatic circulation proposal has been used to
interpret experimental results on the effects of sleep and
anaesthesia on perivascular fluid flow and interstitial vol-
ume in the parenchyma [143,201].
4.4.1 Changes in flow and volume inferred from rates of
delivery of fluorescent markers
Xie et al. found that in awake mice the entry into the par-
enchyma of either of the 3 kDa fluorescent markers, FITC-
dextran or TR-dextran, added via the cisterna magna was
reduced compared to that seen in asleep or anaesthetized
animals [207]. They interpreted their results as demon-
strating the interstitial fluid volume to be less in the awake
state. Some of their data, however, suggest another explan-
ation. The data show that in the awake state the markers
appear along the arteries in the subarachnoid space to a
much smaller extent (or much later?) thus reduced pene-
tration into the parenchyma would follow simply because
the concentration in the periarterial space is lower. If this
is the correct explanation, the observation that the
amount reaching the interstitium was reduced reveals
nothing about the interstitial spaces in the parenchyma.
Although Xie et al. reported examples of data for concen-
trations measured simultaneously in the periarterial space
and in a surrounding annulus of parenchyma, they did not
report ratios of these concentrations [207]. If these ratios
could be obtained they would provide information about
the process of penetration of the markers into the intersti-
tium and might allow conclusions about changes in inter-
stitial volume.
4.4.2 Interstitial fluid volume changes inferred from TMA
iontophoresis measurements
Evidence that the interstitial fluid volume in the cortical
parenchyma may be different in the awake state has been
obtained [207] using the TMA iontophoresis method
[46,99] discussed in section 2.8. If there is no bulk flow and
diffusion is isotropic (the same in all directions), the data
from this method can be interpreted to yield an interstitial
volume fraction and tortuosity. Xie et al. observed that the
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if the rats were asleep than if they were awake. The transi-
tions from the asleep to awake or awake to anaesthetized
states were rapid, e.g. taking 15 min, (see supplementary
material in [207]) and the inferred volume fraction changes
were large, from 23 % to 14 % and 14 % to 23 % respectively.
The experimental data are for regions within 300 μm of the
cortical surface, but they are discussed by Xie et al. as if they
apply to the entire cerebral cortex.
Caveat: As these changes are surprisingly large and
fast it is necessary to ask if there are any confounding
factors in the TMA measurements. Possible factors to
consider include fluid flow, the structure of the extracel-
lular space and voltage gradients with the associated pat-
terns of current flow. For instance if there were fluid flow
in the direction from the injection electrode to the meas-
uring electrode in the awake but not in the sleeping mice
this might account for a higher concentration of TMA
reaching the recording electrode in the awake mice with-
out any volume change. Alternatively a similar result
might be seen if there were more flow in the opposite dir-
ection in the sleeping mice. However, to explain the data
by such mechanisms would involve larger flows than are
currently known to occur (Charles Nicholson and Tony
Gardner-Medwin, personal communications) and would
further require that these flows vary with behavioural
state. (It should be noted, that the estimates of flows in
the literature may be underestimates (sections 4.1 and
4.3.2) as they were based on measurements of outflow of
markers from the cortex during barbiturate anaesthesia.)
Changes of interstitial space configuration (for example
opening or closing of diffusion blockages) seem also un-
likely to account for the data, since they would be ex-
pected to affect the calculated tortuosity, which was not
seen to vary significantly [207]. Thus it is hard at present
to see a clear basis for challenging the inference of an al-
tered space fraction for the regions within 300 μm of the
cortical surface where the measurements were carried out
(see Endnotee).
In a Physiological Society poster, Gardner-Medwin
noted that in rats there is evidence against a large increase
in ISF volume at the onset of sleep [209]. If there were to
be an increase in volume the impedance of the tissue
should decrease, but the only changes in impedance ob-
served have been an increase associated with onset of
rapid eye movement sleep and decrease on return to “nor-
mal” sleep [210,211]. He also proposed for discussion sev-
eral ideas based on movements of ions and water during
slow wave sleep but at present additional experiments are
needed to establish what effects these might have on
TMA diffusion dynamics. Brinker et al. have focussed at-
tention on possible factors other than altered glymphatic
circulation that may have altered the width of interstitial
spaces in animals exposed to the very artificial recordingconditions, including changes in arterial blood pressure,
venous blood pressure, stress hormone levels, and blood
gases [17].
4.4.3 Interstitial fluid volume changes inferred from
radiotracer measurements
Xie et al. also used radiotracers to compare differences
in interstitial fluid volume in awake, asleep or anaesthe-
tized mice [207]. For this purpose they injected either
radiolabelled inulin or amyloid-β into the cortex and
followed the decrease in concentration over time. The
half-time for the decrease was shorter for amyloid-β than
for inulin probably reflecting the fact that amyloid-β is
transported across the blood-brain barrier. The half-times
for decrease for both substances were longer in awake
mice compared to asleep or anaesthetized mice. Xie et al.
interpreted these data (as with their fluorescence data,
section 4.4.1) as implying smaller interstitial fluid volume
and hence smaller rates of transfer within the interstitium
in the awake mice. (For inulin the rate constants were
roughly 0.008 min-1 awake compared to 0.016 min-1
asleep and 0.019 min-1 anaesthetized while for amyloid-β
they were approximately 0.021 min-1, 0.05 min-1 and 0.045
min-1). Caveats: Although the changes in rate constants
may reflect changes in interstitial fluid volume, many
other things may have changed as well.
5 A current view of regulation of the extracellular
fluids of the brain and their constant renewal
The composition of the extracellular fluids and the volume
they occupy clearly have to be regulated to allow effective
functioning of cells in the brain. This regulation is
achieved by the presence of barriers that prevent free ex-
change between CNS and blood and mechanisms for pro-
duction, distribution and reabsorption of fluid hence
providing regular fluid turnover. The application of mod-
ern techniques to the study of the processes involved in
brain fluid turnover has yielded new and important infor-
mation. But in interpreting this information it is important
not to neglect the basic anatomy and physiology of trans-
port and flow. The underlying principle of control of total
extracellular fluid volume in the brain is simple. Fluid is
secreted into the brain at a rate that is relatively insensitive
to changes in intracranial pressure (reviewed in [5,9]).
Fluid is returned from the brain to the blood at a rate
which increases with intracranial pressure. The rate of
fluid return increases with the extracellular fluid volume
because increased volume increases intracranial pressure.
At steady-state, when extracellular volume and intracra-
nial pressure are constant, they take on whatever values
balance inflow and outflow. This process has been consid-
ered extensively in earlier reviews [9,16].
Regulation of the composition of extracellular fluid
(section 1.4) depends primarily on the transport
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been concerned only with the evidence that the net
process is a secretion and not with either the mecha-
nisms or the importance of short-term local control.
The net process must be secretion rather than filtration
because the blood-brain barrier is an effective barrier.
While hydrostatic pressures can drive water fluxes across
the blood-brain barrier, unless these are accompanied by
altered transport of solutes they will soon lead to con-
centration changes that produce osmotic pressures that
oppose the net water fluxes (section 2.7). Viewed the
other way round, solute fluxes, via specific transporters
at the blood-brain barrier will produce osmotic changes
that will force water to follow. These principles were
established many years ago [7,73] but some of their con-
sequences have not been sufficiently widely appreciated.
Importantly, there cannot be significant net reabsorption
of fluid across the intact blood-brain barrier into the
blood unless there is a mechanism for producing net
movement of NaCl across the barrier in the direction
from brain to blood and no such mechanism has been
found or proposed.
Constant turnover of extracellular fluids has been widely
viewed as necessary to provide a non-selective means to re-
move wastes for which there are no specific transporters.
Continual secretion of “clean” fluid into the brain and re-
absorption of whatever fluid is present by non-selective
pressure-driven mechanisms achieves this end. Secretion of
this “clean” fluid is partly the function of the choroid
plexuses and partly the function of the blood-brain barrier.
Perhaps surprisingly the relative contributions by each of
these structures are still not known as their secretion rates
are difficult to determine (sections 3.1.3 and 3.2). ISF flow
which has been assumed to reflect blood-brain barrier se-
cretion rate has been estimated from the rate of removal of
markers from the brain but these measurements are called
into question on two grounds: firstly they were performed
with animals under barbiturate anaesthesia which may have
inhibited both secretion and flow (sections 4.1 and 4.3.2)
and secondly influx of CSF into the parenchyma via peri-
vascular routes may contribute to ISF flow (section 4.3),
which then does not reflect solely blood-brain barrier secre-
tion. The reabsorption of fluid from brain eventually to
blood occurs by a number of mechanisms (reviewed in
[16]), all of which are relatively non-selective and increase
in rate with intracranial pressure.
The broader outlines of brain fluid regulation were
largely established in the older work. Much of more re-
cent work has uncovered more complex fluid move-
ments within the brain that have implications for the
functions and regulation of the extracellular fluids. The
results from PC-MRI measurement of CSF flow rates
(section 4.2) leave no doubt that movement of CSF is
much more extensive and variable than the slow steadyflow envisaged in the classical account, i.e. secretion by
the choroid plexuses and a sedate steady flow to exit
sites. Results of some PC-MRI studies imply that net
flow through the cerebral aqueduct is reversed so that
the net flow is into rather than out of the third and lat-
eral ventricles. Reversed flow has been proposed as the
normal direction for net flow in children under two (in
one study) and as the flow pattern in communicating
hydrocephalus (in a number of studies). Reversal of flow
has important implications, i.e. it requires that there is
an important source of CSF other than the choroid plex-
uses and some means for removing fluid from the third
and lateral ventricles other than via the cerebral aque-
duct. In communicating hydrocephalus the route of re-
moval may be created as a pathological consequence of
the disorder but in children no plausible route has been
proposed. Fluorescent tracer analysis has shown that
flow can occur into the parenchyma along periarterial
spaces. Whether or not this represents net fluid flow
into the cortex and whether there is subsequent flow
through the interstitium between arteriolar and venular
ends of the microcirculation and net flow out of the cor-
tex via perivenous routes, described as the glymphatic
circulation, remain to be established (section 4.3).
6 Conclusion
Fluid is secreted into CSF by the choroid plexuses and
into ISF at the blood-brain barrier. These secretions are
driven by metabolic energy coupled to transport by the
ubiquitous Na+, K+-ATPase, the Na+-pump. Fluid is
returned to lymph and blood by a number of routes
prominently including perineural pathways leading to
the olfactory epithelium and the arachnoid villi. Fluid
cannot be reabsorbed across the blood-brain barrier so
long as the barrier remains intact. The relative rates of
secretion by the choroid plexuses and at the blood-brain
barrier remain uncertain. Similarly more data are re-
quired to be sure of the sources of fluid involved in turn-
over of ISF. Previous estimates of total CSF production
rate including those made by the ventriculo-cisternal
perfusion method may not include a large fraction of the
contribution of ISF secretion at the blood-brain barrier.
Earlier determinations of ISF production rates from
measurements of the rate of efflux of markers from
brain parenchyma may have underestimated the rate of
fluid turnover by as much as 6-fold because experiments
were performed under barbiturate anaesthesia, which
may have suppressed both secretion and turnover. How-
ever, calculations of the rate of secretion at the blood-
brain barrier made using measurements of rates of efflux
of markers from the parenchyma may overestimate the
secretion because fluid turnover mediating the marker
efflux may include perivascular influx of CSF as well as
blood-brain barrier secretion. If the observation of
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contrast magnetic resonance imaging is substantiated,
this would provide strong evidence that the blood-brain
barrier is able to secrete fluid at a substantial rate com-
pared to that of the choroid plexuses. Finally data showing
net influx of CSF into the parenchyma via periarterial
routes may indicate that local convection is occurring in
periarterial spaces both within the subarachnoid spaces
and within the cortex with or without associated flow
through the parenchyma. The field is wide open for fur-
ther experiments!
Endnotes
aThe Starling mechanism does not assume that proteins
cannot cross peripheral capillary walls, only that they cross
sufficiently slowly that they can exert almost their full os-
motic pressure. The filtered fluid has concentrations of
small solutes that are virtually the same as those in
plasma, but the concentration of proteins is about 1/4 of
that in plasma. At any point in time there is approximately
the same amount of plasma protein in the tissues, equal to
(average interstitial concentration of protein) × (total in-
terstitial fluid volume), as in the plasma (plasma protein
concentration in plasma) × (plasma volume). However, be-
cause the interstitial volume is about 4-fold bigger than
the plasma volume there is still a marked difference in
concentration and hence a marked colloid osmotic pres-
sure across the membrane. In the central nervous system
the microvascular permeability to protein is very much
less than in the periphery and the plasma protein concen-
tration in brain interstitium is very small.
bA unidirectional flux of water across a membrane,
barrier or region is the flux of water molecules that start
on one side and end up on the other. A unidirectional
flux is normally measured using a tracer, e.g. for water
often tritiated or deuterated water. Tracer molecules are
added to one side of a membrane at a known fraction of
the total number of water molecules on that side (in-
cluding the tracer). The unidirectional flux of water is
then calculated as the net flux of tracer divided by the
fraction. The net flux of water is the difference between
the unidirectional fluxes in the two directions.
For bulk flow as with the flow of blood along the
length of a blood vessel, the unidirectional flux of water
in the opposite direction to the flow is negligible and the
unidirectional flux in the direction of flow is the same as
the net flux. By contrast for pure diffusion down a gradi-
ent from a higher to a lower concentration, the ratio of
the unidirectional flux in the same direction to the net
flux is (higher concentration)/(difference in concentra-
tion) while the ratio of the unidirectional flux in the op-
posite direction to the net flux is (lower concentration)/
(difference in concentration). For the actual process oc-
curring across peripheral microvascular walls, the ratioof the back flux to the net flux is intermediate between
the values for bulk flow and diffusion but much closer
to that for diffusion. To put it another way, the move-
ment of molecules against the flow in an artery can be
ignored, but not the movements against the net flow
across a capillary wall. The back flux of water is then al-
most as large as the forward flux.
cIn most textbooks the story is told that in peripheral
tissues there is filtration (a net movement out of the
blood) of perhaps 1 % of the blood volume arriving in
the tissue at the arterial ends of capillaries but that as a
consequence of the drop in hydrostatic pressure along
the capillaries there is reabsorption (a net inward move-
ment) at the venous end of 90 % of that filtered leaving
the 0.1 % of blood flow to become lymph. While this
story uses the terms filtration and reabsorption correctly,
it has been known for many years that it is rarely a cor-
rect description largely because it was based on outdated
estimates of the interstitial forces and ignored changes
in the hydrostatic and colloid osmotic pressures within
the tissues and within the endothelial junctions. In those
tissues with no other input of fluid, e.g. skin and muscle,
filtration rather than absorption normally occurs over
the entire length of the microvessels, capillaries and
venules, with the overall amount filtered balanced by
lymph flow. By contrast in tissues that have an input of
a fluid with substantially less protein than plasma, e.g.
the intestines during absorption of a meal or the cortex
of the kidneys, there can be absorption of most of the
added fluid into the vasculature while the rest carries
interstitial protein into lymph. A similar process is
thought to be occurring in the absorption of CSF that
reaches the nasal mucosa (section 4.1).
dThe inability of the intact blood-brain barrier to re-
absorb interstitial fluid has been noted repeatedly. How-
ever from the frequency with which such reabsorption
has been suggested, the point appears not to have been
universally accepted. It may therefore be useful to pro-
vide a simple numerical calculation that emphasizes the
difficulties. Imagine that CSF and ISF production con-
taining 150 mM NaCl is 0.35 ml min-1 and that all of
the reabsorption is occurring by pressure driven flow
across microvessels in the parenchyma. If these have the
normal properties of the blood-brain barrier, the reab-
sorbate will be nearly pure water, which by the hypoth-
esis is being removed from the brain at 0.35 ml min-1.
The net effect is that salt is being added by fluid produc-
tion but is not being removed by fluid reabsorption.
How long will it take to accumulate enough salt in the
brain to stop the net reabsorption of water? The rate of
addition of salt is 0.35 ml min-1 × 0.15 mmol ml-1 ~ 0.0475
mmol min-1. If the total water volume of the brain is taken
to be 1 litre this amounts to a rate of change of concentra-
tion of 0.0475 mM min-1 which is a rate of increase of
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minute the salt build-up can offset a pressure of 0.095
mOsmolal * 19 mmHg mOsmolal-1 = 0.9 mmHg. In other
words, unless there is a means for removing the salt, within
a few minutes the osmolality of the brain will increase to
offset any realistic hydrostatic (or colloid osmotic) pressure
difference that could be driving the reabsorption. The diffi-
culty with postulating pressure driven filtration of fluid
across the blood-brain barrier either into the parenchyma
or out of it is explaining how one moves the salt.
eThe transitions from asleep to awake or awake to
anaesthetized states reported by Xie et al. [207] are
rapid, e.g. taking 15 min, and the inferred volume
changes are large, from 23 % to 14 % and 14 % to 23 %
respectively. They require addition to or removal from
the interstitial spaces of both water and solutes as the
fluid must remain nearly isosmotic with CSF and cells. It
is difficult to imagine how the volume of the interstitium
can be changed by so large a fraction so quickly unless
the change is very localized.
To gain some appreciation of the size of the effects
proposed consider the increase in ISF volume when the
awake mice were anaesthetized. The same percentage
change in ISF volume in humans if it occurred over the
entire brain would require addition of about 90 ml of
fluid containing about 300 mOsmoles of solutes per litre.
These solutes cannot be K+ and Cl− released from cells
for the simple reason that, if maintained throughout a
period of sleep, the increase in extracellular K+ concen-
tration (to about 60 mM) together with the associated
depolarization and sequelae would kill the cells. The sol-
utes have to be primarily Na+ and Cl−. Indeed it would
be very interesting to know if the NaCl content of brain
extracellular fluid is different in the awake and asleep
states as the volume is approximately proportional to
this content.
The only possible mechanisms for NaCl to be added to
the interstitial fluid are efflux from cells, fluxes across the
blood-brain barrier or flow from CSF. The volume of the
cells is much larger than the interstitial volume and thus
even though the intracellular Na+ and Cl− concentrations
are small the cells may contain just about enough NaCl
that if all were effluxed accompanied by water it might ac-
count for the shift. However, it is difficult to imagine how
this could be made to occur. Secretion at the blood-brain
barrier even if it were at the full rate needed for “normal”
production of CSF (about 20 ml h-1) would be much too
slow and there is no known mechanism for subsequent
absorption of fluid by this route upon awakening. Further-
more introduction of fluid into the brain from the blood
would be expected to increase intracranial pressure. That
leaves exchanges with CSF. Can NaCl and water, about
half of that in the entire CSF, be moved into the paren-
chyma from CSF in so short a time?Abbreviations
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